Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Student Posters
All Days
Mon, Dec 5
Tue, Dec 6
Student Posters
Type here to filter the list
Monday, December 5, 2022
10:45 AM – 11:45 AM
(2-002) Retrospective Analysis of 400 Mg Intravenous Tocilizumab for Treatment of Patients Hospitalized with COVID-19
Favorite
10:45 AM – 11:45 AM
(2-003) Assessment of the Accuracy and Safety of Area Under the Curve Vancomycin Dosing Guidelines and Calculator in the Pediatric Population at a Large Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-004) Acceptability and Feasibility of Digital Health Technologies for the Care of Older Adults During the COVID-19 Pandemic: A Systematic Review
Favorite
10:45 AM – 11:45 AM
(2-005) Treatment of Hepatitis C in an Indigent Population
Favorite
10:45 AM – 11:45 AM
(2-006) Introductory Pharmacy Practice Experience (IPPE) Students’ Changes in Knowledge, Attitudes, and Perceptions in Managing the Medical Care of Patients with Health Disparities
Favorite
10:45 AM – 11:45 AM
(2-007) Analysis of Fourth Year Student Pharmacists’ Perceptions of Health Disparities Before and After APPE Learning Experiences at Underserved Outpatient Clinical Practice Sites
Favorite
10:45 AM – 11:45 AM
(2-008) Optimizing Pain Management in the Community Pharmacy Setting Utilizing Preemptive Pharmacogenomic Screening of CYP2D6 and CYP2C9
Favorite
10:45 AM – 11:45 AM
(2-009) Effect of Blood Eosinophils on Corticosteroid Responsiveness During Acute Exacerbations of COPD
Favorite
10:45 AM – 11:45 AM
(2-010) Title: Pharmacist-led Motivational Interviewing Effects on Medication Adherence in Outpatient Clinic Settings: A Systematic Review
Favorite
10:45 AM – 11:45 AM
(2-011) Assessing Control of Asthma and Chronic Obstructive Pulmonary Disease (COPD) in a Charitable Pharmacy
Favorite
10:45 AM – 11:45 AM
(2-012) Beliefs Regarding Mindfulness-Based Stress Reduction for Treatment of Chronic Pain Among the U.S. General Public: A National Survey
Favorite
10:45 AM – 11:45 AM
(2-013) Evaluation of Vasopressin Utilization at a Central Alabama Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-014) Evaluation of Stress Ulcer Prophylaxis in Hospitalized Geriatric Patients
Favorite
10:45 AM – 11:45 AM
(2-015) Comparison of Bamlanivimab/etesevimab and Casirivimab/imdevimab for the Treatment of High-Risk COVID-19 Patients
Favorite
10:45 AM – 11:45 AM
(2-016) Clinical Status and Time to Antiretroviral Initiation in Patients Screened HIV-1 Positive at a Regional Hospital in the Southeast
Favorite
10:45 AM – 11:45 AM
(2-017) Evaluation of Rapid Antiretroviral Therapy Initiation and Transitions of Care of Patients Newly Diagnosed with HIV-1 Infection During Hospitalization
Favorite
10:45 AM – 11:45 AM
(2-018) Retrospective Evaluation of Low-Dose Subcutaneous Tocilizumab for the Treatment of Patients Hospitalized with COVID-19
Favorite
10:45 AM – 11:45 AM
(2-019) Reduction of Paclitaxel Infusion Reactions at an Outpatient Adult Gynecologic/Oncology Infusion Clinic
Favorite
10:45 AM – 11:45 AM
(2-020) Students' Perceptions of the Effectiveness of Near-Peer Teachers in Pharmacy Education
Favorite
10:45 AM – 11:45 AM
(2-021) Two Year Evaluation of Podcasts as the Primary Teaching Method in a Pharmacy Post-Graduate Training Elective
Favorite
10:45 AM – 11:45 AM
(2-022) Best Practices for Promoting Scholarship in Pharmacy Practice
Favorite
10:45 AM – 11:45 AM
(2-023) Sedation Weaning in Patients with an Uncontrolled Psychiatric History
Favorite
10:45 AM – 11:45 AM
(2-024) Impact of a Meds-to-Beds Program on 30-Day Readmissions for CMS-Targeted Conditions
Favorite
10:45 AM – 11:45 AM
(2-025) Comparing the Effects of Heparin Infusion Maximum Dose Limits in Morbidly Obese Patients to Weight-based Dosing in Non-obese Patients
Favorite
10:45 AM – 11:45 AM
(2-026) Evaluation of Melatonin Use on Benzodiazepine and Opioid Requirements and Pain Scores in Critically Ill Pediatric Patients
Favorite
10:45 AM – 11:45 AM
(2-027) Female First and Senior Authorship in Critical Care Publishing
Favorite
10:45 AM – 11:45 AM
(2-028) Students’ Perceptions of the Role of Near-Peer Teachers in Pharmacy Education
Favorite
10:45 AM – 11:45 AM
(2-029) Assessing Adherence to Consensus Recommendations for Prescribing of Omega-3 Fatty Acids in Patients with Atherosclerotic Cardiovascular Disease
Favorite
10:45 AM – 11:45 AM
(2-030) Retrospective Analysis of Partial Fill Prescription Processing at a Veterans Affairs Medical Center (VAMC)
Favorite
10:45 AM – 11:45 AM
(2-031) Development of Novel Doxycycline Topical Formulations to Combat Methicillin Resistant Staphylococcus Aureus
Favorite
10:45 AM – 11:45 AM
(2-032) Evaluation of Antimicrobial Stewardship Practices from a Multi-disciplinary MICU Team at a Small, Non-teaching Hospital
Favorite
10:45 AM – 11:45 AM
(2-033) Assessment of Pharmacist Knowledge and Confidence in Providing Pediatric Vaccinations Before and After Educational Programing
Favorite
10:45 AM – 11:45 AM
(2-034) Deciphering the Reality Behind CBD Oil in a Pre-clinical Model of Alzheimer’s Disease
Favorite
10:45 AM – 11:45 AM
(2-035) Descriptive Review of the Formulation Conversion of Inhaled Corticosteroid/Long-Acting Beta-Agonist (ICS/LABA) Inhalers at a Veterans Affairs Medical Center
Favorite
10:45 AM – 11:45 AM
(2-036) Prepping for PrEP: Evaluating the Impact of an Educational In-service on PrEP Therapy
Favorite
10:45 AM – 11:45 AM
(2-037) Retrospective Review of a Pharmacist-Managed Transitions of Care Service at a Federally Qualified Health Center: Financial and Clinical Outcomes
Favorite
10:45 AM – 11:45 AM
(2-038) Evaluation of Pharmacist-led Medicare Annual Wellness Visits to Satisfy Quality Metrics and USPSTF Recommendations After Implementation of a Post-Visit Follow-Up Protocol
Favorite
10:45 AM – 11:45 AM
(2-039) Evaluation of Clinical Outcomes with Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) Therapy in a Predominantly Underserved Patient Population
Favorite
10:45 AM – 11:45 AM
(2-040) Evaluation of Provider Awareness and Understanding of Stroke Risk and Anticoagulation Therapy in Patients with Non-Valvular Atrial Fibrillation
Favorite
10:45 AM – 11:45 AM
(2-041) Effectiveness and Safety of Transitions from Parenteral Anticoagulation to Rivaroxaban or Apixaban for Venous Thromboembolism Treatment
Favorite
10:45 AM – 11:45 AM
(2-042) Lumacaftor Inhibits cAMP-Dependent Iodide Efflux Through Rescued F508del CFTR in a Bronchial Epithelial Cell Line
Favorite
10:45 AM – 11:45 AM
(2-043) Association of Opioid Utilization in the Medical Intensive Care Unit and Incidence of a New Opioid Prescription in Opioid Naive Patients
Favorite
10:45 AM – 11:45 AM
(2-044) Association of Opioid Use in the Medical Intensive Care Unit and the Prevalence of Opioid Prescribing at Discharge (OMICU)
Favorite
10:45 AM – 11:45 AM
(2-045) Assessing the Appropriateness of Heparin Infusions for the Treatment of Acute Venous Thromboembolism (VTE) at a Tertiary Medical Center
Favorite
10:45 AM – 11:45 AM
(2-046) Investigation of Clinically Relevant Metabolic Interactions Between Levodopa and Cannabinoids
Favorite
10:45 AM – 11:45 AM
(2-047) Assessment of Selective Serotonin Reuptake Inhibitor (SSRI) Prescribing Practices in the Geriatric Outpatient Population with Major Depressive Disorder at a Veterans Affairs (VA) Medical Center
Favorite
10:45 AM – 11:45 AM
(2-048) Evaluating the Safety of Bayesian Modeling versus Two-Level Trapezoidal Area Under the Curve (AUC)-based Dosing of Vancomycin When Used Concomitantly with Piperacillin-Tazobactam
Favorite
10:45 AM – 11:45 AM
(2-049) Impact of Pre-hospital Anticoagulant And/or Antiplatelet Therapy on Clinical Outcomes for Patients Hospitalized with COVID-19
Favorite
10:45 AM – 11:45 AM
(2-050) Incidence and Timing of Reactions in Patients Receiving Subcutaneous Daratumumab
Favorite
10:45 AM – 11:45 AM
(2-051) Assessing Albuterol Prescribing Patterns in Pediatric Patients with Asthma
Favorite
10:45 AM – 11:45 AM
(2-052) Impact of Elexacaftor/Tezacaftor/Ivacaftor on Cystic Fibrosis Associated Gastrointestinal Disease and Symptoms in Pediatric Patients: A Retrospective Analysis
Favorite
10:45 AM – 11:45 AM
(2-054) Observational Assessment of Predictors of Stool DNA Testing and Up-To-Date Screening of Colorectal Cancer
Favorite
10:45 AM – 11:45 AM
(2-055) Predictors of Exercise Engagement Among U.S. Residents Diagnosed with Myalgia
Favorite
10:45 AM – 11:45 AM
(2-056) Outcomes Associated with Methicillin-resistant Staphylococcus Aureus vs. Methicillin-susceptible S. Aureus Coinfections in Coronavirus Disease 2019
Favorite
10:45 AM – 11:45 AM
(2-057) Association of Social Stability with Illicit Drug Use
Favorite
10:45 AM – 11:45 AM
(2-058) Predictors of Receiving Drug Therapy, Counseling, or Both in U.S. Ambulatory-Care Patients Diagnosed with Attention-Deficit Disorder/Attention-Deficit Hyperactivity Disorder (ADD/ADHD)
Favorite
10:45 AM – 11:45 AM
(2-059) Development of an in Vitro Assay for Detection of Nephrotoxicity of Commonly Used Drugs
Favorite
10:45 AM – 11:45 AM
(2-060) Provider Decision-Making in Response to an Automated, Electronic Antibiotic Time-Out Alert After 48 Hours of Antibiotic Therapy
Favorite
10:45 AM – 11:45 AM
(2-061) Risk Factors Associated with Prescription Sedative, Stimulant, and Tranquilizer Drug Abuse with a Focus on Factors Available to a Dispensing Pharmacist
Favorite
10:45 AM – 11:45 AM
(2-062) Pharmacist Impact on Diabetic Ketoacidosis Outcomes in the Emergency Department at Tucson Medical Center
Favorite
10:45 AM – 11:45 AM
(2-063) Evaluation of Student-Led Beta-Lactam Allergy Delabeling at Northwest Medical Center
Favorite
10:45 AM – 11:45 AM
(2-064) Pharmacist Led Interventions in Hepatitis C Management
Favorite
10:45 AM – 11:45 AM
(2-065) Surveying Patients and Pharmacists to Assess the Knowledge of Medication-related Risks in Celiac Disease
Favorite
10:45 AM – 11:45 AM
(2-066) Applying the Health Belief Model to the General Public’s Perceptions of Community-Based Dementia Resources
Favorite
10:45 AM – 11:45 AM
(2-067) Clinical Pharmacist Impact on Patient Pain Scoring over a Four-month Period in a Primary Ambulatory Care Setting
Favorite
10:45 AM – 11:45 AM
(2-068) Influenza Vaccination Perceptions Among Pharmacy Students During the COVID-19 Pandemic
Favorite
10:45 AM – 11:45 AM
(2-069) An Assessment of Vancomycin Target Attainment After Implementation of an Area Under the Concentration-Time Curve Dosing Strategy Using Bayesian Modeling
Favorite
10:45 AM – 11:45 AM
(2-070) Measuring the Impact of an Additional Healthcare Component to a Poverty Simulation on the Attitudes of Interprofessional Healthcare Students
Favorite
10:45 AM – 11:45 AM
(2-071) Evaluating the Impact of Educational Interventions on Prescribing Practices in Pediatric Urinary Tract Infections Between a Non-Academic and an Academic Children’s Hospital
Favorite
10:45 AM – 11:45 AM
(2-072) Addressing Health Disparities in Antimicrobial Prescribing for Urinary Tract Infections in a Pediatric Emergency Department
Favorite
10:45 AM – 11:45 AM
(2-073) Small Cell Lung Carcinoma and Synchronous Rectal Adenocarcinoma and Jejunal Gastrointestinal Stromal Tumor Present in a Patient with History of Laryngeal Squamous Cell Carcinoma
Favorite
10:45 AM – 11:45 AM
(2-074) Effects of Glucagon-Like-Peptide-1 Receptor Agonists (GLP-RA) on Cardiovascular Outcomes in Patients with Chronic Kidney Disease (CKD): A Systematic Review and Meta-Analysis
Favorite
10:45 AM – 11:45 AM
(2-075) Pharmacogenomics Interactions of Drugs Used for Alzheimer’s Disease
Favorite
10:45 AM – 11:45 AM
(2-076) Substance Use Education in U.S. Pharmacy Schools: Fentanyl Test Strips and Other Harm Reduction Strategies
Favorite
10:45 AM – 11:45 AM
(2-077) Pro Re Nata (PRN) Usage of Antipsychotic Medications in an Acute Care Setting
Favorite
10:45 AM – 11:45 AM
(2-078) Surrogate Endpoints Used in Clinical Trials of Esophageal Cancer Therapies Within the United States: A Systematic Literature Review
Favorite
10:45 AM – 11:45 AM
(2-079) Appropriateness of Direct Oral Anticoagulants Dosing in Patients with Nonvalvular Atrial Fibrillation Managed by an Interdisciplinary Team
Favorite
10:45 AM – 11:45 AM
(2-081) Oral Step down Compared to Extended Intravenous Antibiotics Therapy in Patients with Gram-negative Bacteremia: A Retrospective Cohort Study
Favorite
10:45 AM – 11:45 AM
(2-082) Mental Health in Dialysis Nurses During COVID-19
Favorite
10:45 AM – 11:45 AM
(2-083) Evaluation of the in-vitro Antibacterial Activity of SPR206 Against Multidrug- resistant Acinetobacter Baumannii
Favorite
10:45 AM – 11:45 AM
(2-084) Investigating Hemoglobin A1C Change in Patients Who Are Referred to an Ambulatory Care Pharmacist in the Outpatient Setting
Favorite
10:45 AM – 11:45 AM
(2-085) Ivabradine Therapy Appropriateness and Its Implications for Heart Failure Patients
Favorite
10:45 AM – 11:45 AM
(2-086) Evaluation of Sodium Zirconium Cyclosilicate versus Sodium Polystyrene Sulfonate Monotherapy for Acute Hyperkalemia
Favorite
10:45 AM – 11:45 AM
(2-087) Development of an in Vitro Co-culture Model to Study the Interactions Between Acute Myeloid Leukemia Cells and Blood Brain Barrier Cells
Favorite
10:45 AM – 11:45 AM
(2-088) Relationship Between Lipid Formulation and Central Line Associated Bloodstream Infections in Patients Requiring Parenteral Nutrition
Favorite
10:45 AM – 11:45 AM
(2-089) Comparing Single to Multiple Block Scheduling of the Advanced Pharmacy Practice Experiences (APPE) at Desert Valley Hospital (DVH) from 2021 to 2022
Favorite
10:45 AM – 11:45 AM
(2-090) Racial Disparities in Management and Treatment of Cystitis at a Large Academic Emergency Department and Urgent Care Settings
Favorite
10:45 AM – 11:45 AM
(2-091) The Antipsychotic Chlorpromazine (Thorazine) for Treatment of Pain
Favorite
10:45 AM – 11:45 AM
(2-092) The Influence of hsa-miR-370-3p and CYP2D6 on Steady-state Concentration of Paroxetine in Patients with Depressive Disorder
Favorite
10:45 AM – 11:45 AM
(2-093) Acute Effects of Enhanced External Counterpulsation (EECP) on Cardiac Output
Favorite
10:45 AM – 11:45 AM
(2-094) Changes in Perceived Stress of Pharmacy Students Pre- and Mid-COVID-19 Pandemic
Favorite
10:45 AM – 11:45 AM
(2-095) Cost-Utility Analysis of Academic Detailing Outreach on Naloxone Prescribing for Patients at Risk of Opioid-Related Overdose
Favorite
10:45 AM – 11:45 AM
(2-096) Trends in Concomitant Opioid and Benzodiazepine Exposures Reported to California Poison Control System Following CDC Release of 2016 Opioid Guidelines
Favorite
10:45 AM – 11:45 AM
(2-097) Views and Perceptions of Medical Representatives and Physicians About the Role of Medical Representatives and Pharmaceutics Advertisement in Saudi Arabia – a Pilot Study
Favorite
10:45 AM – 11:45 AM
(2-098) Comparison of Healthcare Expenditures Among People with Diabetes with and Without Mental Health Disorders
Favorite
10:45 AM – 11:45 AM
(2-099) Pediatric Cystic Fibrosis Pharmacist Clinic Visit Outcome Analysis: A Four-Year Follow-Up
Favorite
10:45 AM – 11:45 AM
(2-100) Impact of Elexacaftor/Tezacaftor/Ivacaftor on Pulmonary Function Tests in Adult and Pediatric Cystic Fibrosis Patients
Favorite
10:45 AM – 11:45 AM
(2-101) Assessment of Healthcare Providers’ Knowledge and Attitudes Towards Opioid Misuse Before and After a Hybrid, Inter-professional Opioid Overdose Workshop
Favorite
10:45 AM – 11:45 AM
(2-102) Value of Expanding Intern Pharmacists’ Clinical Responsibilities in an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-103) Outcome of Enoxaparin Bridging in Left Ventricular Assist Devices in an Ambulatory Care Setting
Favorite
10:45 AM – 11:45 AM
(2-104) Assessing the Current Landscape of Direct-to-Consumer Advertising: An Analysis of Prescription Product Advertisements Found in Consumer Magazines
Favorite
10:45 AM – 11:45 AM
(2-106) Industry Pharmacist Job Satisfaction Analysis
Favorite
10:45 AM – 11:45 AM
(2-107) Pharmacy Implication of FDA’s Diversity Plan for Clinical Trials
Favorite
10:45 AM – 11:45 AM
(2-108) Alteplase versus Tenecteplase for Acute Ischemic Stroke: A Retrospective Cohort Analysis
Favorite
10:45 AM – 11:45 AM
(2-109) The Impact of Online Learning on Academic Performance and Confidence in Pharmacy Student Learning Outcomes
Favorite
10:45 AM – 11:45 AM
(2-110) The Impact of Clinical Equations on Carboplatin Dosing: A Systematic Review to Determine Appropriate Dosing of Carboplatin in Adult Cancer Patients
Favorite
10:45 AM – 11:45 AM
(2-111) Implementation of Tenecteplase for Acute Ischemic Stroke (AIS) at a Comprehensive Stroke Center (CSC) Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-112) Emergency Preparedness: Food Insecurity During COVID-19 Pandemic
Favorite
10:45 AM – 11:45 AM
(2-113) Rare Case of Varicella Zoster Meningitis
Favorite
10:45 AM – 11:45 AM
(2-114) B Cells from Individuals with Trisomy 21 Have Altered Activation Compared to Disomic Individuals
Favorite
10:45 AM – 11:45 AM
(2-115) Changes in Self Perceived Student Stress in P1, P2, and P3 Pharmacy Students at Regis University
Favorite
10:45 AM – 11:45 AM
(2-116) West Nile Virus Meningoencephalitis
Favorite
10:45 AM – 11:45 AM
(2-117) Factors Associated with Unscheduled Return Visits to the Emergency Department: A Case-control Study
Favorite
10:45 AM – 11:45 AM
(2-118) Characteristics of Patients Treated with Romosozumab as Compared to Parathyroid Hormone Analogs
Favorite
10:45 AM – 11:45 AM
(2-119) Guiding Central Inventory Optimization in an Inpatient Community Hospital Pharmacy
Favorite
10:45 AM – 11:45 AM
(2-120) Post-intubation Sedation Practices Within Emergency Departments Across a Large Pediatric Healthcare Organization
Favorite
10:45 AM – 11:45 AM
(2-121) Assessment of Analgesic Pain Control in Living Donor Nephrectomy Patients After Implementation of an Opioid Stewardship Initiative
Favorite
10:45 AM – 11:45 AM
(2-122) Impact of a Pharmacy Intern in a Heart Failure Clinic
Favorite
10:45 AM – 11:45 AM
(2-123) Evaluation of the Effectiveness of a Pharmacist-Led Diabetes Management Protocol on A1c Reduction in Patients with Uncontrolled Diabetes
Favorite
10:45 AM – 11:45 AM
(2-124) Retrospective Evaluation of the Effectiveness of a Clinical Pharmacy Driven Quality Improvement Initiative Targeting Blood Pressure Control
Favorite
10:45 AM – 11:45 AM
(2-125) Evaluation of an Institutional Anticoagulant Thromboprophylaxis Protocol for Hospitalized Patients Infected with the COVID-19 Delta or Omicron Variants
Favorite
10:45 AM – 11:45 AM
(2-126) Patient Health Outcomes Related to Pharmacy Intervention in Medication Reconciliation
Favorite
10:45 AM – 11:45 AM
(2-127) Hospital-compounded Dextrose Injection 50% Stored in Polypropylene Syringes Maintains Potency for at Least 90 Days in a Stability Sensing Assay
Favorite
10:45 AM – 11:45 AM
(2-128) Evaluation of Short Acting Intramuscular Olanzapine Use in the Emergency Department at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-129) Evaluation of an Argatroban Protocol for Confirmed/Suspected Heparin Induced Thrombocytopenia (HIT)
Favorite
10:45 AM – 11:45 AM
(2-130) Dosing and Operational Evaluation of Human Prothrombin Complex in a Multi-Site Hospital System
Favorite
10:45 AM – 11:45 AM
(2-131) Adherence to Atypical Antipsychotic Monitoring Recommendations in a Primary Care Clinic for Children and Youth with Special Health Care Needs (CYSHCN)
Favorite
10:45 AM – 11:45 AM
(2-132) Evaluation of Home Test Kits to Streamline Healthcare Utilization for Urinary Tract Infections (UTI)
Favorite
10:45 AM – 11:45 AM
(2-133) Use of Sodium Hypochlorite and Hydrogen Peroxide to Decontaminate Compound Areas
Favorite
10:45 AM – 11:45 AM
(2-134) Proposal to Remove Rifaximin 550mg Tablets from Formulary in Favor of 200mg Tablets at Hartford Healthcare
Favorite
10:45 AM – 11:45 AM
(2-135) Potential Risk of Direct Oral Anticoagulant Use in Patients with Inflammatory Bowel Disease
Favorite
10:45 AM – 11:45 AM
(2-136) Characteristics of a Safety Net Population with Uncontrolled Hypertension: A Cross-Sectional Analysis
Favorite
10:45 AM – 11:45 AM
(2-137) Prescribing Patterns’ Alignment with Congestive Heart Failure Recommendations Among Patients Who Received Transitions of Care Services from a Health Systems Integrated Community Pharmacy
Favorite
10:45 AM – 11:45 AM
(2-138) Bromocriptine for Central Hyperthermia After Acute Brain Injury: A Retrospective Cohort Study
Favorite
10:45 AM – 11:45 AM
(2-139) Assessing Appropriate Intravenous Levetiracetam Use in Two Community Hospitals
Favorite
10:45 AM – 11:45 AM
(2-140) Evaluation of the Impact of Home Based Primary Care (HBPC) on COVID-19 Vaccination Rates
Favorite
10:45 AM – 11:45 AM
(2-141) Where to Start with Medication Safety? A Review of the Institute for Safe Medication Practice’s Resource Library
Favorite
10:45 AM – 11:45 AM
(2-142) Assessing Covid-19 Vaccine Waste in a Healthcare System
Favorite
10:45 AM – 11:45 AM
(2-143) Treatment of Babesiosis in a Patient with Complex Cardiovascular History and Chronically Elevated QTc: Azithromycin Plus Atovaquone
Favorite
10:45 AM – 11:45 AM
(2-144) The Impact of Berberine Alone vs. Control on Lipoprotein Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis
Favorite
10:45 AM – 11:45 AM
(2-145) Impact of Berberine-Containing Products versus Active Drug or Dietary Therapy on Lipoprotein Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis
Favorite
10:45 AM – 11:45 AM
(2-146) Comparing the Outcomes of Transitions of Care Services Among Hispanics with and Without Limited-English Proficiency Through a Health System’s Integrated Community Pharmacy
Favorite
10:45 AM – 11:45 AM
(2-147) Supporting Underrepresented and Marginalized Students in Predominantly White Institutions Through Mentorship Programs
Favorite
10:45 AM – 11:45 AM
(2-148) Identifying the Ideal Pediatric Residency Candidate: A Residency Program Director's Perspective
Favorite
10:45 AM – 11:45 AM
(2-149) Evaluation of Hepatitis B Vaccine in Liver Cirrhosis Patients
Favorite
10:45 AM – 11:45 AM
(2-150) Evaluation of Pharmacist Interventions to Initiate Continuous Blood Glucose Monitoring in Patients at a Federally Qualified Health Center
Favorite
10:45 AM – 11:45 AM
(2-151) Evaluation of Guideline-Directed International Normalized Ratio Goal for Outpatient Anticoagulation Management
Favorite
10:45 AM – 11:45 AM
(2-152) HBCU vs Non-HBCU Pharmacy Residency Match Rate
Favorite
10:45 AM – 11:45 AM
(2-153) Impact of a Clinical Pharmacist on Medication Adherence in Patients with Bipolar Disorder
Favorite
10:45 AM – 11:45 AM
(2-154) Impact of a Clinical Pharmacist on Immunosuppressive Medication Adherence in Kidney Transplant Patients
Favorite
10:45 AM – 11:45 AM
(2-155) Comparison of Acute Psychiatric Inpatient Treatment Strategies of Patients with Bipolar Disorders with Length of Stay and Other Parameters
Favorite
10:45 AM – 11:45 AM
(2-156) An Analysis of Antipsychotic Drug Therapy in Patients with Schizoaffective Disorder
Favorite
10:45 AM – 11:45 AM
(2-157) Coronavirus Disease (COVID-19) Vaccine Schedule Compliance: A Retrospective Analysis in a Population of Medically Underserved and Underinsured Adults in Northwest Florida
Favorite
10:45 AM – 11:45 AM
(2-158) An Evaluation of Pharmacist Burnout During COVID-19
Favorite
10:45 AM – 11:45 AM
(2-160) Impact of Telehealth Services for the Management of Type I and II Diabetes Mellitus
Favorite
10:45 AM – 11:45 AM
(2-161) Monitoring Outpatients on Amiodarone Therapy at the James A. Haley Veterans’ Hospital (JAHVH)
Favorite
10:45 AM – 11:45 AM
(2-162) Time to Goal: Evaluation of Heparin Infusion Protocols at a Newly Opened Acute Care Hospital
Favorite
10:45 AM – 11:45 AM
(2-163) Medication Use Evaluation of Fosphenytoin Therapeutic Drug Monitoring in the Intensive Care Unit at Sarasota Memorial Health Care System (SMHCS)
Favorite
10:45 AM – 11:45 AM
(2-164) Comparing Sarasota Memorial Health Care System (SMHCS) Postoperative Opioid Prescribing Practices at Hospital Discharge to National Recommendations
Favorite
10:45 AM – 11:45 AM
(2-165) Comparison of the Differential Pharmacokinetic Parameters for Ensuring Safe and Effective Cannabis Therapeutic Use in Epilepsy
Favorite
10:45 AM – 11:45 AM
(2-166) Evaluation of Efficacy and Safety of Tirzepatide for the Treatment of Type 2 Diabetes
Favorite
10:45 AM – 11:45 AM
(2-167) Retrospective Medication Use Evaluation of Hydromorphone 2mg Intravenous Push Utilization in Hospitalized Adult Patients at a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-168) Initiation of Dofetilide Following Rapid Transition from Amiodarone
Favorite
10:45 AM – 11:45 AM
(2-169) Results of a Pilot Study for Pharmacy Discharge Review in Neurosurgical Patients: A Quality-Safety Initiative
Favorite
10:45 AM – 11:45 AM
(2-170) Clinical Development of Dupilumab for Moderate to Severe Atopic Dermatitis: A Literature Review
Favorite
10:45 AM – 11:45 AM
(2-171) Evaluating the Effect of Intravenous Meloxicam on Postoperative Opioid Use in Orthopedic Surgeries
Favorite
10:45 AM – 11:45 AM
(2-172) Evaluation of Intravenous Minocycline Restriction Criteria in the Inpatient Setting at a Community-Based Healthcare System
Favorite
10:45 AM – 11:45 AM
(2-173) Evaluation of Glucagon Use in Hospitalized Adult Patients
Favorite
10:45 AM – 11:45 AM
(2-174) Prevalence of Urate-Lowering Therapy Use Among Adults with Gout and the Relationship Between Gout Treatment Status and Associated Comorbidities
Favorite
10:45 AM – 11:45 AM
(2-175) The Use of Beers List Medication in Patients 40-64 Years Old Compared to Patients 65 and Older
Favorite
10:45 AM – 11:45 AM
(2-176) Rare Multisystem Inflammatory Syndrome in Adults (MIS-A): A Case Report
Favorite
10:45 AM – 11:45 AM
(2-177) Primary Data Review and Supplemental Aid for Clinicians Using Antineoplastic Agents in Patients Requiring Dialysis
Favorite
10:45 AM – 11:45 AM
(2-178) Factor VII, VIII and IX Product Utilization in a Multicenter Community Health Care System
Favorite
10:45 AM – 11:45 AM
(2-179) Impact of an Outpatient Palliative Care Clinic on Emergency Department Visits/Hospitalizations for Established Palliative Care Patients
Favorite
10:45 AM – 11:45 AM
(2-180) Prevalence of Psychotropic Drug Use in Children Aged 6-17: NHANES 2013-2018
Favorite
10:45 AM – 11:45 AM
(2-181) Utilization of the Cytochrome P450 Drug-Drug Interaction Between Olanzapine and Fluvoxamine to Improve Symptoms in Schizophrenia: A Case Report
Favorite
10:45 AM – 11:45 AM
(2-182) Potential Benefit of Naltrexone in a Patient with Autistic Disorder and Borderline Personality Disorder Exhibiting Self Injurious Behaviors
Favorite
10:45 AM – 11:45 AM
(2-183) Medication Use Evaluation of SGLT2 Inhibitors in a Community Healthcare System
Favorite
10:45 AM – 11:45 AM
(2-184) Evaluating the Prevalence of Inappropriate Correctional Insulin Prescribing Practices at Discharge Across a Healthcare System
Favorite
10:45 AM – 11:45 AM
(2-185) Optimization of Medication Request Workflow to Reduce Medication Delays
Favorite
10:45 AM – 11:45 AM
(2-186) Controlling Blood Pressure During a Pandemic: The Impact of Telepharmacy for Primary Care Patients
Favorite
10:45 AM – 11:45 AM
(2-187) An Evaluation of Pharmacist Interventions Within a Primary Care Clinic on 30 and 90 Day Heart Failure Readmission Rates
Favorite
10:45 AM – 11:45 AM
(2-188) Evaluating the Role of Factor XI(a) Inhibition in Preventing Venous Thromboembolisms
Favorite
10:45 AM – 11:45 AM
(2-189) Analysis of the Use of Pantoprazole Dosed up to Four Times Daily in Patients with Peptic Ulcer Disease
Favorite
10:45 AM – 11:45 AM
(2-190) Chlorthalidone versus Hydrochlorothiazide: A Comparison of Efficacy and Safety Outcomes in the Existing Literature
Favorite
10:45 AM – 11:45 AM
(2-191) Implementation of a Pharmacist-Led Long-Acting Injectable Antiretroviral Therapy Service at a Hospital-Based Infectious Disease Clinic
Favorite
10:45 AM – 11:45 AM
(2-192) Assessing the Impact of Candida Auris on a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-193) Chronic Medication Use Among People with HIV Compared to the General Population
Favorite
10:45 AM – 11:45 AM
(2-194) Clinical and Economic Impact of Blood Culture Contamination at a Multi-Center Health System
Favorite
10:45 AM – 11:45 AM
(2-195) Eradication of Resistant and Non-resistant H. Pylori Infection with Vonoprazan: A Review
Favorite
10:45 AM – 11:45 AM
(2-196) Effect of Radiation Therapy on CD4 Count in HIV Patients with Undetectable Viral Load
Favorite
10:45 AM – 11:45 AM
(2-197) Assessing the Impact of Chlorpromazine Dose Equivalents on Acute Agitation Episodes in Patients with Schizophrenia and Schizoaffective Disorder
Favorite
10:45 AM – 11:45 AM
(2-198) Management of Cyclic Catatonia in a Bipolar Patient Using Lithium
Favorite
10:45 AM – 11:45 AM
(2-199) Assessment of Provider Knowledge and Therapeutic Approaches for Reducing Stroke Risk in Patients with Nonvalvular Atrial Fibrillation
Favorite
10:45 AM – 11:45 AM
(2-200) Financial Reimbursement of a Student Pharmacist and Pharmacy Resident-Run Chronic Care Management Program in a Privately-Owned Family Medicine Clinic
Favorite
10:45 AM – 11:45 AM
(2-201) Evaluation of Daratumumab and Hyaluronidase (Darzalex Faspro) Administration-related Reactions at a Community Cancer Center
Favorite
10:45 AM – 11:45 AM
(2-202) Evaluating Pharmacy Students’ Perceptions on the Need for Post-Graduate Training Pre- and Post-COVID-19 Pandemic
Favorite
10:45 AM – 11:45 AM
(2-203) Combatting Misinformation and Vaccine Hesitancy in Underrepresented South Florida Populations
Favorite
10:45 AM – 11:45 AM
(2-204) Optimizing an Inpatient Hospital’s Pharmacy Technician Operation to Improve Medication Delivery and Reduce Delays in Patient Care
Favorite
10:45 AM – 11:45 AM
(2-205) Retrospective Medication Use Evaluation of Intravenous Albumin Administration in Hospitalized Adult Patients at a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-206) Lenacapavir: An Investigational Long-Acting Capsid Inhibitor for the Treatment of Human Immunodeficiency Virus 1 Infection (HIV-1)
Favorite
10:45 AM – 11:45 AM
(2-207) High-Evidence Actionable Pharmacogenomics in a Multispecialty, Tertiary Care Clinic
Favorite
10:45 AM – 11:45 AM
(2-208) The Prescribing Patterns of Urinary Tract Infection Management in Adult Patients at a Free Student-Run Free Clinic: A Retrospective Study
Favorite
10:45 AM – 11:45 AM
(2-209) Dose Impact on Hypoglycemia After Administration of IV Regular Insulin for the Treatment of Hyperkalemia
Favorite
10:45 AM – 11:45 AM
(2-210) Using Thiamine Supplementation in Lactic Acidosis Where Blood Pressure Is Already Optimized: A Retrospective Analysis
Favorite
10:45 AM – 11:45 AM
(2-211) Medication Use Evaluation of Injectable Promethazine in the Emergency Department Setting at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-212) Chlorpromazine Injection in the Emergency Department
Favorite
10:45 AM – 11:45 AM
(2-213) Defining Key Pharmacist and Technician Roles in Response to a Hospital Downtime or Cyberattack
Favorite
10:45 AM – 11:45 AM
(2-214) Assessment and Management of Extended Spectrum Beta-Lactamase Urinary Tract Infections in Patients from the Emergency Care Center or Urgent Care Center
Favorite
10:45 AM – 11:45 AM
(2-215) User Experience Evaluation of the Current Format for Clinical Pharmacogenomics Consult Documentation
Favorite
10:45 AM – 11:45 AM
(2-216) Efficacy of a Revised Tool on Identifying Patients at Risk for Opioid-induced over Sedation and Respiratory Depression
Favorite
10:45 AM – 11:45 AM
(2-217) Effect of a Pharmacist Driven Pediatric Heparin Protocol on Time to Therapeutic Levels in a Pediatric Intensive Care Unit
Favorite
10:45 AM – 11:45 AM
(2-218) Acute Respiratory Failure – Is It COVID-19 or Cannabis?
Favorite
10:45 AM – 11:45 AM
(2-220) Evaluation of CHA2DS2-VASc in Atrial Fibrillation Patients Receiving Anticoagulation in the Outpatient Setting
Favorite
10:45 AM – 11:45 AM
(2-221) Evaluation of Anticoagulation Administration Post Cardiac Ablation in Patients with Atrial Fibrillation
Favorite
10:45 AM – 11:45 AM
(2-222) Comparison of Heparin Nomograms on Time to Therapeutic Partial Thromboplastin Time (PTT)
Favorite
10:45 AM – 11:45 AM
(2-223) Association of Genetic Polymorphisms and Loop Diuretic Interactions with Survival in Patients with Heart Failure
Favorite
10:45 AM – 11:45 AM
(2-224) Determining the Effect of Bivalirudin on INR Levels in Hospitalized Patients Receiving Warfarin Bridging Therapy
Favorite
10:45 AM – 11:45 AM
(2-225) Driving Sustainable Clinical Practice Change to Optimize Outcomes for Patients with Hypercholesterolemia - Scale Up: Integration of the PA Checklist in Clinical Practice
Favorite
10:45 AM – 11:45 AM
(2-226) Establishing Internal Medicine Pharmacist Services by Resource Reallocation and Hospitalist Collaboration
Favorite
10:45 AM – 11:45 AM
(2-227) Effectiveness of Inhaled Epoprostenol as Compared to Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome
Favorite
10:45 AM – 11:45 AM
(2-228) Venous Thromboembolism Prophylaxis Dosing and Incidence of Thrombosis in Trauma Patients at a Level II Trauma Center
Favorite
10:45 AM – 11:45 AM
(2-229) Monitoring Temperature in Targeted Temperature Management in an Anatomically-Limited Patient
Favorite
10:45 AM – 11:45 AM
(2-230) Improving Analgesia with Methadone After Large Burn Injury
Favorite
10:45 AM – 11:45 AM
(2-231) Concomitant Use of Levothyroxine and Interacting Medications in US Ambulatory Care Visits
Favorite
10:45 AM – 11:45 AM
(2-232) Efficacy of 10% Dextrose Compared to 50% Dextrose for Treatment of Acute Hypoglycemia
Favorite
10:45 AM – 11:45 AM
(2-233) Evaluating Appropriate Use of Albumin 25% Intravenous Solution at a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-234) Evaluating Antihypertensive Medication Usage in Patients with Apparent Treatment Resistant Hypertension (aTRH) Within the State of Florida Using Electronic Health Record (EHR) - Based Data
Favorite
10:45 AM – 11:45 AM
(2-235) Drug Use Evaluation of Micafungin
Favorite
10:45 AM – 11:45 AM
(2-236) Evaluation of Antibiotic Utilization and Opportunities for Improved Prescribing in a VA Community-Based Outpatient Clinic
Favorite
10:45 AM – 11:45 AM
(2-237) Use of Psychotropic Medications with Pharmacogenomics Implications at a Multi-State Pediatric Health System
Favorite
10:45 AM – 11:45 AM
(2-238) Evaluation of a Weight-Based Heparin Drip Protocol for Patients with Higher Risk of Intracerebral Bleed Due to an Acute Ischemic Stroke
Favorite
10:45 AM – 11:45 AM
(2-239) Boosting Tacrolimus Trough Concentrations with a Cytochrome-P450 3A4 Inhibitor
Favorite
10:45 AM – 11:45 AM
(2-240) Chloroprocaine for Epidural Labor Analgesia in a Patient with Lidocaine Allergy: A Case Report
Favorite
10:45 AM – 11:45 AM
(2-241) Culture Negative Tropheryma Whipplei Endocarditis: A Case Report
Favorite
10:45 AM – 11:45 AM
(2-242) Prevention of Pneumonia in Post-ROSC Patients Using Broad-Spectrum Antibiotics
Favorite
10:45 AM – 11:45 AM
(2-243) Impact of a Pharmacist-Led Transitions of Care Protocol Implemented in a Geriatric Outpatient Clinic
Favorite
10:45 AM – 11:45 AM
(2-244) Effects of a System Implemented Anticoagulation Management Protocol for Impella CP Patients
Favorite
10:45 AM – 11:45 AM
(2-245) Functionality Assessment of Gene-Disease Pharmacogenomic Clinical Decision Support (PGx-CDS) Implementation in a Clinical Practice Setting
Favorite
10:45 AM – 11:45 AM
(2-246) Ascorbic Acid’s Use in Reducing the Incidence of Methemoglobinemia in Patients Treated with Inhaled Nitric Oxide in ARDS/COVID19
Favorite
10:45 AM – 11:45 AM
(2-247) Optimizing Naloxone Education and Distribution for Veterans with an Opioid Use Disorder Diagnosis
Favorite
10:45 AM – 11:45 AM
(2-248) Mental Health Trends in Transgender Adults Receiving Gender-Affirming Hormone Therapy at a Student-Run Free Clinic
Favorite
10:45 AM – 11:45 AM
(2-249) Protein C Replacement Therapy in Adults with Meningococcemia and Purpura Fulminans
Favorite
10:45 AM – 11:45 AM
(2-250) Evaluation of Blood Glucose After Administration of Intravenous Insulin for the Treatment of Hyperkalemia
Favorite
10:45 AM – 11:45 AM
(2-251) Medication Use Evaluation of Iron Sucrose for Iron-Deficiency Anemia: A Multicenter, Retrospective Analysis
Favorite
10:45 AM – 11:45 AM
(2-252) Retrospective Analysis of Sodium Zirconium Cyclosilicate Use for Hyperkalemia in a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-253) Impact of Avoiding Use of a Pain Scale Within PRN Comments on Pain Medication Orders on a Patient’s Overall Opioid Use
Favorite
10:45 AM – 11:45 AM
(2-254) Analysis of Student Outcomes from an Interprofessional Education Transitions of Care Simulation
Favorite
10:45 AM – 11:45 AM
(2-255) Does Utilizing Low Fidelity Simulations in a Clinical Pharmacokinetics and Pharmacodynamics Course Enhance Student Performance on Similar Skills During APPE Rotations?
Favorite
10:45 AM – 11:45 AM
(2-256) Comparing Combined Oral Contraceptives: Norethindrone/ Ethinyl Estradiol and Drospirenone/ Ethinyl Estradiol
Favorite
10:45 AM – 11:45 AM
(2-257) Evaluation of Agitation or Delirium-Induced Antipsychotic Initiation from ICU to Hospital Discharge in a Community Teaching Hospital
Favorite
10:45 AM – 11:45 AM
(2-258) Assessing Outcomes of Patients Concomitantly on Cobicistat or Ritonavir for HIV Antiretroviral Therapy and a Long Acting Beta2-Agonist
Favorite
10:45 AM – 11:45 AM
(2-259) Characterization of Patients with COPD and Heart Failure Who Enroll in a Bedside Medication Delivery Service
Favorite
10:45 AM – 11:45 AM
(2-260) Use of Intrathecal Milrinone for Refractory Cerebral Vasospasm in a Pediatric Patient with a Traumatic Subarachnoid Hemorrhage
Favorite
10:45 AM – 11:45 AM
(2-261) Evaluating Defibrotide Use for Prevention and Treatment of Veno-Occlusive Disease in High-Risk Pediatric Bone Marrow Transplant Patients
Favorite
10:45 AM – 11:45 AM
(2-262) Evaluating the Implementation of an Electronic-Based Diabetic Ketoacidosis Protocol in the Emergency Department
Favorite
10:45 AM – 11:45 AM
(2-263) Mid-Twentieth to Twenty-first Century Public Health Emergencies as a Catalyst for the Evolution of the Practice of Pharmacy
Favorite
10:45 AM – 11:45 AM
(2-264) The Role of Pharmacists Within an AIDS Service Organization in JYNNEOS Vaccine and TPOXX Acquirement, Inventory, and Administration During the Monkeypox Public Health Outbreak
Favorite
10:45 AM – 11:45 AM
(2-265) Copper Deficiency in Hospitalized Patients with Liver Disease
Favorite
10:45 AM – 11:45 AM
(2-266) Evaluation of Risk Factors for Vitamin B6 Deficiency in Adult Hospitalized Patients
Favorite
10:45 AM – 11:45 AM
(2-267) Caplacizumab Use Postpartum to Treat Immune-Mediated Thrombotic Thrombocytopenic Purpura
Favorite
10:45 AM – 11:45 AM
(2-268) Comparison of Two Cohorts of an International Vaccination Delivery Certificate Training Program
Favorite
10:45 AM – 11:45 AM
(2-269) Retrospective Review of Clinical Outcomes After Intravenous to Oral Conversion
Favorite
10:45 AM – 11:45 AM
(2-270) Impact of a US-Based Telemedicine Service on Patient Clinical Outcomes in Nigeria
Favorite
10:45 AM – 11:45 AM
(2-271) Patient and Healthcare Volunteer Experiences During a Multidisciplinary Virtual Medical and Surgical Mission Trip
Favorite
10:45 AM – 11:45 AM
(2-272) Evaluation of Basiliximab for Induction in Liver Transplant Patients
Favorite
10:45 AM – 11:45 AM
(2-273) Recently Reported Side Effects and Drug Interactions of Antivirals
Favorite
10:45 AM – 11:45 AM
(2-274) Pharmacists’ Attitudes Towards Firearm Violence on Workplace Safety
Favorite
10:45 AM – 11:45 AM
(2-275) Establishing an Interprofessional and Collaborative Continuous Glucose Monitoring Service in a Family Medicine Graduate Medical Education Clinic
Favorite
10:45 AM – 11:45 AM
(2-276) Risk-Benefit Analysis of a Patient with Ehlers-Danlos Syndrome Presenting with Hemostatic Abnormalities
Favorite
10:45 AM – 11:45 AM
(2-277) Evaluating the Impact of Early Switch from Intravenous to Oral Antibiotics in Established Antimicrobial Stewardship Programs
Favorite
10:45 AM – 11:45 AM
(2-278) Role of Anti-PD-1/PD-L1 Therapy in Infectious Disease
Favorite
10:45 AM – 11:45 AM
(2-279) Voxelotor Effects on Hemoglobin Levels in Children with Sickle Cell Disease
Favorite
10:45 AM – 11:45 AM
(2-280) Acetaminophen Toxicity: Treatment with Acetylcystine and Fomepizole
Favorite
10:45 AM – 11:45 AM
(2-281) Efficacy and Safety of Therapeutic Drug Monitoring in Pediatrics with Inflammatory Bowel Disease Using Anti-Tumor Necrosis Factor Antibodies
Favorite
10:45 AM – 11:45 AM
(2-282) Evaluating Hyponatremia in Patients Receiving Sodium Glucose Co-Transporter 2 Inhibitors (SGLT-2i)
Favorite
10:45 AM – 11:45 AM
(2-283) Safety and Efficacy of Brexanolone as a Novel Treatment Option for Postpartum Depression: A Systematic Review
Favorite
10:45 AM – 11:45 AM
(2-284) In vitro High Throughput Screening for the Inhibitory Effect of Phytochemicals Against SARS-CoV-2 Proteolytic and Deubiquitinase Activities
Favorite
10:45 AM – 11:45 AM
(2-285) Traumatic Induced Intracranial Hemorrhage Stroke Management in 32 Year Old African American Male
Favorite
10:45 AM – 11:45 AM
(2-286) Recently Reported Side Effects and Drug Interactions of Antifungal Medications
Favorite
10:45 AM – 11:45 AM
(2-287) The Electronic Health Record Objective Structured Clinical Examination Station
Favorite
10:45 AM – 11:45 AM
(2-288) Assessment of Ghanaian Pharmacists and Residents’ Awareness of Expedited Partner Therapy and Their Views Toward It Receiving Governmental Support
Favorite
10:45 AM – 11:45 AM
(2-289) The Impact of Patient Interactions via Telehealth with Migrant and Seasonal Agricultural Workers on Student Pharmacist Confidence and Avoidance Behavior
Favorite
10:45 AM – 11:45 AM
(2-290) Consumers’ Reasons for Purchasing Over-the-counter Products Marketed for Cardiovascular Health
Favorite
10:45 AM – 11:45 AM
(2-291) The Impact of Patient Interactions with Limited English Proficient Patients via Telehealth on Student Pharmacist Confidence in Using Skilled Interpreters
Favorite
10:45 AM – 11:45 AM
(2-292) Student Pharmacists Increase Migrant and Seasonal Agricultural Workers’ Access to Comprehensive Medication Information Using Telehealth
Favorite
10:45 AM – 11:45 AM
(2-293) Treatment with MDL 72527 Suppressed Optic Nerve Inflammation in an Experimental Model of Multiple Sclerosis
Favorite
10:45 AM – 11:45 AM
(2-294) Effect of Prescribing GLP-1 Agonists on Weight and Insulin Dose in Patients Maintained on Insulin Therapy
Favorite
10:45 AM – 11:45 AM
(2-295) Milrinone Compared with Dobutamine on Impella Support Duration in Patients with Cardiogenic Shock
Favorite
10:45 AM – 11:45 AM
(2-296) Mapping Georgia Community Pharmacies and Clinics: An Evaluation of Diabetes Mellitus Outcomes and Access to Care
Favorite
10:45 AM – 11:45 AM
(2-297) Evaluation of the Utilization and Prescribing Practices of Tolvaptan at a Level 1 Trauma Center in Southeast Georgia
Favorite
10:45 AM – 11:45 AM
(2-298) Tixagevimab-cilgavimab: Access, Equity, and Outcomes at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-299) Gastric Bypass-Related Hyperammonemia
Favorite
10:45 AM – 11:45 AM
(2-300) Evaluating Synagis Usage in an Outpatient Setting
Favorite
10:45 AM – 11:45 AM
(2-301) Evaluation of Combination Opioid and Benzodiazepine Therapy in Spinal Cord Injury Patients Treated with a Benzodiazepine for Spasticity Management at a Veterans Affairs Medical Center
Favorite
10:45 AM – 11:45 AM
(2-302) Evaluation of a Chronic Care Management Pilot Project and Revenue Projections for Sustainability
Favorite
10:45 AM – 11:45 AM
(2-303) Assessing Interventions After Identification of Prolonged Corrected QT Intervals
Favorite
10:45 AM – 11:45 AM
(2-304) Comparing Characteristics Among Black Heart Failure with Reduced Ejection Fraction (HFrEF) Patients Based on Renin-Angiotensin System (RAS) Inhibitor Use at a Veterans Affairs Medical Center
Favorite
10:45 AM – 11:45 AM
(2-305) Impact of Pharmacist-Led Interventions as Part of a Clinical Rounding Team
Favorite
10:45 AM – 11:45 AM
(2-306) Mapping Georgia Community Pharmacies and Clinics: An Evaluation of Healthcare Utilization and Care Access Points
Favorite
10:45 AM – 11:45 AM
(2-307) Mapping Georgia Community Pharmacies and Clinics: An Evaluation of Kidney Disease Outcomes and Access to Care
Favorite
10:45 AM – 11:45 AM
(2-308) Benzodiazepine Use Within 72 Hours of Intubation in Intensive Care Unit (ICU) Patients After De-emphasizing Benzodiazepine Use in a Mechanical Ventilation Order Set
Favorite
10:45 AM – 11:45 AM
(2-309) Analgosedation Practices and Delirium in Patients Receiving Neuromuscular Blocking Agents
Favorite
10:45 AM – 11:45 AM
(2-310) Achievement of Electrolyte Targets with a Nurse-Driven Electrolyte Replacement Protocol in Adult Intensive Care Unit Patients
Favorite
10:45 AM – 11:45 AM
(2-311) Adherence to a Nurse-Driven Bowel Regimen Protocol in Critically Ill Patients at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-312) Evaluation of Corticosteroids Duration on Outcomes in Critically Ill Patients with COVID-19 at a Large, Urban Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-313) Improving PharmD Student Confidence Discussing Social Determinants of Health (SDoH) Topics with Patients
Favorite
10:45 AM – 11:45 AM
(2-314) Evaluation on the Duration of Micafungin Use and De-escalation Following (1,3)-β-D-Glucan (BDG) Testing in Patients at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-315) Resistance of Escherichia coli Urinary Isolates in Patients with Healthcare-associated Urinary Tract Infections Treated in the Emergency Department of a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-316) Evaluation of Trough-Based Vancomycin Protocol in Adult Intensive Care Unit (ICU) Patients at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-317) Trough-Based Monitoring for Vancomycin Dosing in the Non-Intensive Care Patient Population at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-318) Resistance of Escherichia Coli Urinary Isolates in Patients with Community-acquired Urinary Tract Infections Treated in the Emergency Department of a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-319) Discrepancy in Vancomycin Minimal Inhibitory Concentration Per Vitek 2 and E-Test in Methicillin-Resistant Staphylococcus Aureus Bloodstream Isolates
Favorite
10:45 AM – 11:45 AM
(2-320) Review of Antimicrobial Changes Made in a Safety Net Health System Community Outpatient Antimicrobial Therapy Program
Favorite
10:45 AM – 11:45 AM
(2-321) Implementation and Evaluation of a Pharmacist and Nurse Driven Electrolyte Replacement Protocol at an Infusion Center
Favorite
10:45 AM – 11:45 AM
(2-322) Assessment of Molecular Profiling Results and Time to Treatment in the Lung Cancer Population
Favorite
10:45 AM – 11:45 AM
(2-323) Assessment of Pharmacy Student Skills upon Entering Advanced Pharmacy Practice Experiences
Favorite
10:45 AM – 11:45 AM
(2-324) Assessment of Summer 2022 Pharmacy Dispensing Log for Mobile Pharmacy Clinic in the Farm Worker Family Health Program in Rural Southwest Georgia
Favorite
10:45 AM – 11:45 AM
(2-325) Oxycodone Prescriptions upon Hospital Discharge for Kidney Transplant Recipients
Favorite
10:45 AM – 11:45 AM
(2-326) Geographic Accessibility to Contraceptives and the Potential Impact of Pharmacist Prescribing: Comparing Georgia Counties with Majority Non-white versus Majority White Demographics
Favorite
10:45 AM – 11:45 AM
(2-327) Evaluation of Appropriate Prescribing of Statins in Type 2 Diabetics After Recommendations Made by Pharmacy in Academic Medical Center and Medical Associates Clinics
Favorite
10:45 AM – 11:45 AM
(2-328) Evaluation of Amiodarone Use for the Prevention of New Onset Post-Operative Atrial Fibrillation in Cardiac Surgery Patients
Favorite
10:45 AM – 11:45 AM
(2-105) A Mock OSCE for First-Year Pharmacy Students and Its Impact on Self-Reported Confidence in Applying the Pharmacist’s Patient Care Process (PPCP)
Favorite
10:45 AM – 11:45 AM
(2-219) A Comprehensive Evaluation of Valproic Acid Use Among Women of Child-Bearing Age in the United States
Favorite
10:45 AM – 11:45 AM
(2-053) A Retrospective Study of Social and Medical History as Predictors of Stimulant Prescription
Favorite
12:00 PM – 1:00 PM
(3-088) A Continuation of Antibiotic Stewardship Intervention in the Optimization of Duration of Therapy for Community Acquired Pneumonia
Favorite
12:00 PM – 1:00 PM
(3-001) Medicare Prescribing Trends of Canagliflozin and Empagliflozin Nationally and in Hawaii from 2013 to 2020
Favorite
12:00 PM – 1:00 PM
(3-002) Medicare Prescribing Trends of Statins, Fibrates, and Omega-3 Fatty Acids from 2013 to 2020
Favorite
12:00 PM – 1:00 PM
(3-003) Comparison of Antibiotic Prescribing Trends and Clostridiodes difficile Infection (CDI) Rates in the United States from 2019-2020
Favorite
12:00 PM – 1:00 PM
(3-004) An Analysis of FDA Approved Drugs from 2018-2022
Favorite
12:00 PM – 1:00 PM
(3-005) Prevalence of Potentially Inappropriate Medications for Older Adults on Cardiovascular and Endocrine Drugs in a Family Medicine Clinic
Favorite
12:00 PM – 1:00 PM
(3-006) Comparison of Furosemide Prescribing and Heart Failure Hospitalizations by State from 2017 to 2019
Favorite
12:00 PM – 1:00 PM
(3-007) Comparative Health Behavioral Analysis Between Filipino Adults and Caucasian Adults in Hawaii with Association to Diabetes, Overweight, and Obesity Prevalence
Favorite
12:00 PM – 1:00 PM
(3-008) Examining Naloxone Distribution in Accordance with Prescription Opioid-Related Deaths
Favorite
12:00 PM – 1:00 PM
(3-009) Evaluation of Potentially Inappropriate Nonbenzodiazepine Receptor Agonist Hypnotics Prescribing Among the Elderly Medicare Patients by Prescriber Type in the United States and Hawai’i
Favorite
12:00 PM – 1:00 PM
(3-011) COVID-19 Vaccines Impact on 2021 Coronavirus Disease 2019 (COVID-19) Related Deaths versus Hospitalizations by State
Favorite
12:00 PM – 1:00 PM
(3-012) Examining Prevention Quality Indicators (PQI), Cost, and Length of Stay for Diabetes Across Counties in Hawai’i
Favorite
12:00 PM – 1:00 PM
(3-013) Obesity and Diabetes Correlation and the Pharmacist’s Role in Diabetes Prevention Programs
Favorite
12:00 PM – 1:00 PM
(3-014) Evaluation of Lipid-Lowering Regimens in Patients with Diabetes Mellitus
Favorite
12:00 PM – 1:00 PM
(3-015) Comparison of Medicare Statin Prescribing and Stroke Deaths in the United States from 2017 to 2019
Favorite
12:00 PM – 1:00 PM
(3-016) Possible Azathioprine Induced Posterior Reversible Encephalopathy Syndrome (PRES) During the Management of Acute Exacerbation of Systemic Lupus Erythematosus (SLE)
Favorite
12:00 PM – 1:00 PM
(3-017) Assessing the Use of Insulin and Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in a Primary Care Clinic
Favorite
12:00 PM – 1:00 PM
(3-018) Project ADVOCATE: Antibody Distribution via Outstanding Critical Attention to Treatment Effectiveness
Favorite
12:00 PM – 1:00 PM
(3-019) CONSTRUCT- Creating an Online Network Site and Teaching Repository Utilizing Case-based Trainings: Utilizing Backwards Design and the ECHO Model
Favorite
12:00 PM – 1:00 PM
(3-020) Impact of Pharmacist-Led Medication Reconciliation on a Pediatric Outpatient Population
Favorite
12:00 PM – 1:00 PM
(3-021) Desmopressin for Intracerebral Hemorrhage in Patients on Antiplatelet Agents
Favorite
12:00 PM – 1:00 PM
(3-022) Analysis of Direct-To-Industry Jobs Among 2021 Doctor of Pharmacy Graduates
Favorite
12:00 PM – 1:00 PM
(3-023) Comparison of Measured Glomerular Filtration Rate of Humanized Vancomycin Infusion versus Vancomycin Bolus Followed by Saline Infusion in Sprague-Dawley Rats
Favorite
12:00 PM – 1:00 PM
(3-024) Recommending over the Counter Products to Pregnant Patients: What Do Practicing Pharmacists and Healthcare Students Think?
Favorite
12:00 PM – 1:00 PM
(3-025) The Marine Pharmacology and Pharmaceuticals Pipeline in 2022
Favorite
12:00 PM – 1:00 PM
(3-026) The Effect of Daily Meditation on Stress, Mindfulness, Well-being, and Resilience in Student Pharmacists
Favorite
12:00 PM – 1:00 PM
(3-027) Impact of Social Determinants of Health on COVID-19 Vaccine Hesitancy Among Vulnerable Populations
Favorite
12:00 PM – 1:00 PM
(3-028) The Impact of Mental Health During the COVID-19 Pandemic
Favorite
12:00 PM – 1:00 PM
(3-029) Continuation of Antipsychotics Initiated in the ICU at Unit Transfer and Hospital Discharge
Favorite
12:00 PM – 1:00 PM
(3-030) Evaluation of Intravenous Regular Insulin Use and Subsequent Hypoglycemia During Treatment of Hyperkalemia in a Large Multi-Site Hospital System
Favorite
12:00 PM – 1:00 PM
(3-031) An Evaluation of Outpatient Pediatric Asthma Prescribing Patterns in the United States
Favorite
12:00 PM – 1:00 PM
(3-033) Opioid Antagonist Utilization Patterns in U.S. Emergency Department Visits
Favorite
12:00 PM – 1:00 PM
(3-034) Assessment of National Trauma Trends for Motor Vehicle Accidents
Favorite
12:00 PM – 1:00 PM
(3-035) Paxlovid Eligibility in Patients Who Received Bebtelovimab for COVID-19 Treatment
Favorite
12:00 PM – 1:00 PM
(3-036) Metacognition of Interprofessional Education: Critical Discourse Analysis of an Interprofessional Healthcare Simulation
Favorite
12:00 PM – 1:00 PM
(3-037) Utilizing a Toxicology Digital Simulation Framed by the Pharmacists’ Patient Care Process to Prepare Students for Advanced Pharmacy Practice Experiences and Clinical Practice
Favorite
12:00 PM – 1:00 PM
(3-038) Evaluation of an Initial Tacrolimus Starting Dose After Simultaneous Kidney-Pancreas Transplant at a Large Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-039) Impact of COVID-19 on the Academic Performance of Graduate Healthcare Students
Favorite
12:00 PM – 1:00 PM
(3-040) QTc Prolongation Observed with Haloperidol Administration in Hospitalized Patients
Favorite
12:00 PM – 1:00 PM
(3-041) Evaluation of Acetaminophen for Patent Ductus Arteriosus in the Neonatal Intensive Care Unit
Favorite
12:00 PM – 1:00 PM
(3-042) Student Pharmacist Interest in a Pharmaceutical Industry Preparation Elective Course: A Cross-sectional Survey
Favorite
12:00 PM – 1:00 PM
(3-043) Patient Perceptions of Student Pharmacist Communication and Roles in Pharmacy Practice
Favorite
12:00 PM – 1:00 PM
(3-044) Evaluating the Impact of Vaccine Education on Vaccine Hesitancy in African American Mothers
Favorite
12:00 PM – 1:00 PM
(3-045) Assessing Adherence to Guideline Recommendations on Initial Selection of Pharmacological Treatment for Hypertension at a General Internal Medicine Clinic in Metropolitan Central Illinois
Favorite
12:00 PM – 1:00 PM
(3-046) Impact of Clinical Service Integration with Pharmacy Students on Pharmacist Cost Savings
Favorite
12:00 PM – 1:00 PM
(3-047) Evaluation of Teaching Methods for Pharmacist Documentation
Favorite
12:00 PM – 1:00 PM
(3-048) Assessment of the Citation Frequency of Retracted Articles in Medical Literature
Favorite
12:00 PM – 1:00 PM
(3-049) Impact of Antimicrobial Stewardship Services in a Community Teaching Hospital
Favorite
12:00 PM – 1:00 PM
(3-050) Gram-Negative Bacteremias: Frequency of an IOTA (Intravenous to Oral Transition of Antimicrobial Therapy)
Favorite
12:00 PM – 1:00 PM
(3-051) Clinical Impact of a Pharmacist-led, Multidisciplinary Pain Management Service in a Primary Care Setting: A Retrospective Review
Favorite
12:00 PM – 1:00 PM
(3-052) Impact of Dexmedetomidine Initiation on Cardiovascular and Oxygenation in Critically Ill Preterm Neonates
Favorite
12:00 PM – 1:00 PM
(3-053) Analyzing Drug Interactions with Risk of QT Prolongation and the Utility of the Tisdale Scoring System
Favorite
12:00 PM – 1:00 PM
(3-054) Evaluation of a Pharmacist-Led Opioid Use Disorder Treatment Service: A Retrospective Cross-Sectional Study
Favorite
12:00 PM – 1:00 PM
(3-055) Evaluation of Safety and Efficacy of Tenecteplase for Acute Ischemic Strokes: A Retrospective Study
Favorite
12:00 PM – 1:00 PM
(3-056) U.S. Schools of Pharmacy Application and Expense Landscape and the Effect of COVID-19
Favorite
12:00 PM – 1:00 PM
(3-057) Sucralfate Slurry for the Treatment of Gastric Ulcers in a Patient with Dysphagia
Favorite
12:00 PM – 1:00 PM
(3-058) Development and Implementation of a Student Led Project to Optimize Financial Assistance for Patients Treated with Oral Anticancer Agents in a Health System Specialty Pharmacy
Favorite
12:00 PM – 1:00 PM
(3-059) Coronavirus Disease 2019 (COVID-19) Vaccination Rates Among Incarcerated Patients with Hepatitis C Virus (HCV) Infection
Favorite
12:00 PM – 1:00 PM
(3-060) Single-center Analysis of the Effects of a Video Education Intervention on Immunosuppressant Adherence in Kidney Transplant Recipients
Favorite
12:00 PM – 1:00 PM
(3-062) Impact of a Student-Run Warfarin Education Program on Post-Hospital Discharge Follow-Up Appointments
Favorite
12:00 PM – 1:00 PM
(3-063) Mail Order Outcomes in Kidney Transplant Cohort
Favorite
12:00 PM – 1:00 PM
(3-064) Impact of Clinical Research Design Elective Course on Students' Confidence in Research Skills
Favorite
12:00 PM – 1:00 PM
(3-065) Outpatient Pharmacy Management of Dispensing Extended-Release Injectable Buprenorphine for Opioid Use Disorder at a Federally Qualified Health Center
Favorite
12:00 PM – 1:00 PM
(3-066) Comparative Analysis of Phenobarbital and Non-Phenobarbital Based Alcohol Withdrawal Syndrome Regimens
Favorite
12:00 PM – 1:00 PM
(3-067) Barriers to Naloxone Dispensing in Community Pharmacies: Comparing Results from a 2021 and 2022 Educational Outreach Initiative
Favorite
12:00 PM – 1:00 PM
(3-068) Perioperative Desensitization with Intravenous Immunoglobulin vs. Bortezomib in Positive Crossmatch Deceased Donor Kidney Transplants: 12-Months Outcomes Analysis
Favorite
12:00 PM – 1:00 PM
(3-069) Evaluation of Ambulatory Care Pharmacist-led Nirmatrelvir/Ritonavir Prescribing on Rates of Hospitalization for COVID-19
Favorite
12:00 PM – 1:00 PM
(3-070) The Safety and Tolerability of High Dose Intravenous Push Levetiracetam
Favorite
12:00 PM – 1:00 PM
(3-071) Intravenous High Dose Hydrocortisone versus Intravenous Low Dose Hydrocortisone in Patients with Septic Shock
Favorite
12:00 PM – 1:00 PM
(3-072) Delirium in the Intensive Care Unit – Analysis on the Prescribing and Deprescribing Rates of Quetiapine
Favorite
12:00 PM – 1:00 PM
(3-073) Swabbing Our Way to Better Stewardship: The Impact of Pharmacist Driven MRSA Nares PCR Protocol on Duration of Vancomycin Therapy for Pneumonia
Favorite
12:00 PM – 1:00 PM
(3-074) Evaluation of Rituximab Use at Parkview Health
Favorite
12:00 PM – 1:00 PM
(3-075) Appropriateness of Outpatient Management of Urinary Tract Infections at an Urban, Safety-Net, Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-076) Antibiotic Use and Appropriate Indications in Community Acquired Pneumonia (CAP)
Favorite
12:00 PM – 1:00 PM
(3-077) Assessing a Novel Education Tool to Improve Knowledge and Reduce Stigma of a Syringe Service Program (SSP) for Substance Use at the Indianapolis VA
Favorite
12:00 PM – 1:00 PM
(3-078) Inducing Alternative Forms of Cell Death in Multi-Drug Resistant Ovarian Cancer Cells
Favorite
12:00 PM – 1:00 PM
(3-079) Evaluation of Intensive Care Unit (ICU) Medication Transitions of Atypical Antipsychotics
Favorite
12:00 PM – 1:00 PM
(3-080) When Slow and Steady State Does Not Win: Initial Peak Anti-Xa Levels in Enoxaparin for Venous Thromboembolism (VTE) Prophylaxis in Burn Patients
Favorite
12:00 PM – 1:00 PM
(3-081) Evaluation of Therapies for Treatment of Hyponatremia
Favorite
12:00 PM – 1:00 PM
(3-082) Evaluation of Epoetin Alfa Use in End Stage Renal Disease at University of Louisville Health
Favorite
12:00 PM – 1:00 PM
(3-083) Impact of Optimizing Smart Infusion Pump Dose Error Reduction Systems (DERS) on Opioid Ordering for Naïve versus Tolerant Patients
Favorite
12:00 PM – 1:00 PM
(3-084) Roles of Alternative Splicing and Differential Expression in Fluoxetine Response
Favorite
12:00 PM – 1:00 PM
(3-085) Concordance of Indexed Medical Subject Headings with Clinician-generated Population, Intervention, Comparison, Outcome (PICO) Terms
Favorite
12:00 PM – 1:00 PM
(3-086) Scope and Completeness of Drug Information for Pregnancy and Lactation in Electronic Tertiary Databases
Favorite
12:00 PM – 1:00 PM
(3-087) Characterization of Vancomycin Use at a Community Hospital
Favorite
12:00 PM – 1:00 PM
(3-089) Continued Use of Proton Pump Inhibitors and Risk for Recurrence of Clostridium Difficile Infection-A Retrospective Study
Favorite
12:00 PM – 1:00 PM
(3-090) Fidaxomicin Use for Initial and Recurrent Clostridioides Difficile Infections at a Community Hospital in Northern Indiana
Favorite
12:00 PM – 1:00 PM
(3-091) Enhanced Recovery After Surgery (ERAS): Multimodal Pain Regimen in Heart Transplant and Left Ventricular Assist Device Surgery
Favorite
12:00 PM – 1:00 PM
(3-092) Evaluation of Laboratory Protocol for Cerebral Spinal Fluid Specimens to Identify Opportunities to Optimize Diagnostic Reflex Testing with Polymerase Chain Reaction in Meningitis Patients
Favorite
12:00 PM – 1:00 PM
(3-093) Evaluation of Cytochrome P450 Inhibition by the Synthetic Cathinones Butylone and MDPPP
Favorite
12:00 PM – 1:00 PM
(3-094) Efficacy of Transitions of Care Management (TCM) Services in Reducing Hospital Readmission Rates
Favorite
12:00 PM – 1:00 PM
(3-095) Diabetic Services Surveys
Favorite
12:00 PM – 1:00 PM
(3-096) Assessing Anticoagulation Management in Patients on Concomitant Rifampin
Favorite
12:00 PM – 1:00 PM
(3-097) Incidence of Hypertriglyceridemia in ICU Admitted COVID-19 Who Received Propofol for Mechanical Sedation
Favorite
12:00 PM – 1:00 PM
(3-098) Health Equity Language Within Residency Training Promotional Content
Favorite
12:00 PM – 1:00 PM
(3-099) Evaluation of Treatment of Alcohol Withdrawal in a Community Hospital
Favorite
12:00 PM – 1:00 PM
(3-100) Ask-Advise-Refer to the Tobacco Quitline: Implementing Brief Tobacco Cessation Interventions During Community-Based Health Events
Favorite
12:00 PM – 1:00 PM
(3-101) Symptom Guided Recommendations to Support Clinical Decision Making in Deprescribing Anticholinergic Antidepressant Medications
Favorite
12:00 PM – 1:00 PM
(3-102) Implementation of 5S Methodology in a Central Pharmacy at a Large Academic Hospital
Favorite
12:00 PM – 1:00 PM
(3-103) Evaluation of Post-Surgical Discharge Amiodarone Monitoring and Toxicities at a Cardiac Care Center in the United Kingdom
Favorite
12:00 PM – 1:00 PM
(3-104) Adherence to Secondary Preventative Medications Following Acute Myocardial Infarction
Favorite
12:00 PM – 1:00 PM
(3-105) Evaluation of Pharmacy Intervention and Utilization of Indiana University Health Methodist Hospital’s Meds in Hand Program at Discharge from the Cardiac Progressive Care Unit
Favorite
12:00 PM – 1:00 PM
(3-106) Evaluation of Epinephrine Use as a Push-dose Vasopressor in the Non-operating Room Setting
Favorite
12:00 PM – 1:00 PM
(3-107) Comparison of Self-Reported Medication Inventory and Medication Orders Data Among Elderly Anticholinergic Users for Quantification of Medication Risks
Favorite
12:00 PM – 1:00 PM
(3-108) Medication Use Evaluation of Ceftriaxone Prescribing Practices in Community Acquired Pneumonia and Urinary Tract Infection at a Large Single-Center Institution
Favorite
12:00 PM – 1:00 PM
(3-109) Evaluation of Perampanel for Refractory Status Epilepticus or Super-Refractory in the Neurological Intensive Care Unit at an Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-110) Evaluation of Guideline Recommended Treatment Duration for Hospitalized Patients Diagnosed with Uncomplicated Community Acquired Pneumonia
Favorite
12:00 PM – 1:00 PM
(3-111) Evaluation of Naloxone Use and Opioid-induced Unintended Sedation Monitoring Practices at an Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-112) Potential Impact of Preemptive Pharmacogenetic Testing in Critically Ill Neonates
Favorite
12:00 PM – 1:00 PM
(3-113) Trends in Toxicologic Exposures Requiring Pediatric Intensive Care Unit Admission Pre and During COVID-19
Favorite
12:00 PM – 1:00 PM
(3-114) Assessing the Effect of Calibrated Peer Review on Student Pharmacist Confidence with the Pharmacists’ Patient Care Process
Favorite
12:00 PM – 1:00 PM
(3-115) Evaluation of Healthcare Learners’ Self-Assessments Surrounding an Interprofessional and Culturally-Focused Simulation Activity
Favorite
12:00 PM – 1:00 PM
(3-116) Current Status of Tobacco Cessation Education in Doctor of Pharmacy Programs in the U.S
Favorite
12:00 PM – 1:00 PM
(3-117) Evaluating Social Media as a Pharmacovigilance Monitoring Tool
Favorite
12:00 PM – 1:00 PM
(3-118) Evaluating Accuracy of Adverse Drug Reaction Reporting in a Health System's Ambulatory Infusion Setting
Favorite
12:00 PM – 1:00 PM
(3-119) Improving the Safe Dispensation of Oral Methotrexate for Non-Oncological Purposes in a Primary Care Center Pharmacy
Favorite
12:00 PM – 1:00 PM
(3-120) Evaluation of the Safety of Direct-acting Oral Anticoagulants vs. Warfarin for Portal Vein Thrombosis Anticoagulation After Liver Transplant
Favorite
12:00 PM – 1:00 PM
(3-121) Evaluation of Contraindications and Precautions in a Pharmacist Hormonal Contraception Prescribing Service
Favorite
12:00 PM – 1:00 PM
(3-122) Evaluation of Risankizumab Use in Daegu Catholic University Medical Center
Favorite
12:00 PM – 1:00 PM
(3-124) National Strategies to Optimize Taiwan's Drug Supply Chain and Mitigate Drug Shortages Amid COVID-19 Pandemic
Favorite
12:00 PM – 1:00 PM
(3-125) Psoriasiform Inflammation Is Associated with Mitochondrial fission/GDAP1L1 Signaling in Macrophages
Favorite
12:00 PM – 1:00 PM
(3-126) Growth Evaluation After Using Postnatal Dexamethasone in Very Low Birth Weight (VLBW) Infants
Favorite
12:00 PM – 1:00 PM
(3-127) Evaluation of Health-Related Information Seeking Behavior Through the Internet in Korean Adults: A Cross-Sectional Survey
Favorite
12:00 PM – 1:00 PM
(3-128) Predictive Factors of Searching Dietary Supplements Through the Internet Among Korean Adults
Favorite
12:00 PM – 1:00 PM
(3-129) Validation of Media Health Literacy Evaluation Tool for Korean Adult
Favorite
12:00 PM – 1:00 PM
(3-130) Development and Validation of a Medication-based Fall Risk Prediction Model in Community-dwelling Elderly Using a National Claims Database – a Machine Learning Approach
Favorite
12:00 PM – 1:00 PM
(3-131) Assessing Visitors’ Satisfaction of Smoking Cessation Clinics and Services: A Cross-sectional Study in Saudi Arabia
Favorite
12:00 PM – 1:00 PM
(3-132) Biomarkers in Alzheimer´s Disease: Clinical Aspects
Favorite
12:00 PM – 1:00 PM
(3-133) Proton Pump Inhibitors Alone or in Combination with Octreotide in Upper Gastrointestinal Bleeding: A Retrospective Observational Study
Favorite
12:00 PM – 1:00 PM
(3-134) Pharmacist-led Identification of Drug-Related Problems in Discharge Patients: A Cross-Sectional Study
Favorite
12:00 PM – 1:00 PM
(3-135) Accuracy of A1c Testing When Conducted Through Capillary Point-of-care Testing Machines as Compared to Venous Blood Draw
Favorite
12:00 PM – 1:00 PM
(3-136) Assessment of Pharmacy Staff Knowledge on Access to Language Services to Complete Inpatient Medication Reconciliations at a 2,000 Bed Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-137) Integration of Pharmacy Students into Clinical Internships in the Workplace
Favorite
12:00 PM – 1:00 PM
(3-138) Evaluation of Heparin Line Labeling After Implementation of Process Improvement Initiatives
Favorite
12:00 PM – 1:00 PM
(3-139) Medication Use Evaluation of a Therapeutic Enoxaparin Collaborative Practice Monitoring Protocol
Favorite
12:00 PM – 1:00 PM
(3-140) Assessment of Warfarin Monitoring Outcomes After Implementation of an Optional Pharmacy Consult Service
Favorite
12:00 PM – 1:00 PM
(3-141) Heparin-induced Thrombocytopenia (HIT) Best Practice Alert (BPA) Overfiring
Favorite
12:00 PM – 1:00 PM
(3-142) Training Experiences of Postgraduate Year 2 Pain Management and Palliative Care Pharmacy Residency Graduates
Favorite
12:00 PM – 1:00 PM
(3-143) Improving Pharmacist Efficiency and Efficacy in Hypertension Management with Use of a Remote Blood Pressure Monitoring System
Favorite
12:00 PM – 1:00 PM
(3-144) Evaluation of Inpatient Use of Eculizumab, a Restricted Formulary Drug
Favorite
12:00 PM – 1:00 PM
(3-145) Rare Spontaneous Candida Albicans Peritonitis in a Patient with Chronic Alcohol Abuse and Liver Disease: A Case Presentation
Favorite
12:00 PM – 1:00 PM
(3-146) Evaluation of Alaris® Infusion Pump Integration Compliance Within Saint Luke’s Health System
Favorite
12:00 PM – 1:00 PM
(3-147) Real-world Maintenance Rituximab Dosing Practices in Patients with ANCA-associated Vasculitis
Favorite
12:00 PM – 1:00 PM
(3-148) What’s Neu with HER2? Characterization of HER2-Low Breast Cancer Tumors and Genomes
Favorite
12:00 PM – 1:00 PM
(3-149) Improving the Prediction of Cefepime-induced Neurotoxicity in Critically Ill Patients: Risk Factor Exploration of a Neurotoxicity Prognostic Tool
Favorite
12:00 PM – 1:00 PM
(3-150) Thematic Analysis of Student Perception of a Social Determinants of Health and Disparities Simulation Activity
Favorite
12:00 PM – 1:00 PM
(3-151) Accessibility of Diabetes Therapy for Patients with Visual Impairment
Favorite
12:00 PM – 1:00 PM
(3-152) Accessibility of Ocular Drug Product Websites
Favorite
12:00 PM – 1:00 PM
(3-153) Systematic Review and Formulary Evaluation of Acute Treatment Options for Hereditary Angioedema in a Large Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-154) Evaluation of Smart Pump Dose Error Reduction Systems at a Large Academic Health System
Favorite
12:00 PM – 1:00 PM
(3-155) Proposed Cost Savings at a Health System If Monoclonal Antibodies Are Rounded down to the Nearest Vial Size Within Ten Percent of the Prescribed Dose
Favorite
12:00 PM – 1:00 PM
(3-156) Evaluation of a Hypoglycemia Protocol in Newborns at a Community Hospital
Favorite
12:00 PM – 1:00 PM
(3-157) Evaluation of Indomethacin and Acetaminophen for Patent Ductus Arteriosus (PDA) Closure in Preterm Neonates
Favorite
12:00 PM – 1:00 PM
(3-158) Evaluation of Prescribing Frequency of Range Orders That Comply with Revised Organization Policy at an Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-159) Evaluation of a Monthly Audit Tool for Automated Dispensing Cabinets in Patient Care Units at a Large Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-160) Evaluation of Rabbit Anti-Thymocyte Globulin Induction Dosing in Renal Transplant Patients Using Actual Body Weight versus Ideal Body Weight
Favorite
12:00 PM – 1:00 PM
(3-161) Topical vs Oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Safety Medical Use Evaluation
Favorite
12:00 PM – 1:00 PM
(3-162) Evaluation of Sugammadex Use at a Community Hospital
Favorite
12:00 PM – 1:00 PM
(3-163) Quality Improvement Study: Colorectal Surgery Implementing Opioid Prescribing Limits
Favorite
12:00 PM – 1:00 PM
(3-164) Amiodarone Induced Thyrotoxicosis
Favorite
12:00 PM – 1:00 PM
(3-165) Availability of Pharmacist Care Services in Medically Underserved Areas in Kentucky via Board-approved Protocols
Favorite
12:00 PM – 1:00 PM
(3-166) Case Report: Methylphenidate for Hypoactive Delirium in the Intensive Care Unit
Favorite
12:00 PM – 1:00 PM
(3-167) Targeted Thrombolytic Therapy Delivered via Pulmonary Artery Catheter for Massive Pulmonary Embolism
Favorite
12:00 PM – 1:00 PM
(3-168) Progression of Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam or Cefepime in Sepsis-Associated Acute Kidney Injury
Favorite
12:00 PM – 1:00 PM
(3-169) Impact of the COVID-19 Pandemic in the Rates of Depression and Anxiety Across the United States: A Systemic Review
Favorite
12:00 PM – 1:00 PM
(3-170) History of Antibiotic Adverse Reactions and the Incidence of Asymptomatic Bacteriuria Treatment at a Single Veterans Affairs Health Care System
Favorite
12:00 PM – 1:00 PM
(3-171) Medication Use Evaluation of Methylnaltrexone at a Rural, Community Hospital
Favorite
12:00 PM – 1:00 PM
(3-172) Profile of Adverse Drug Reactions Reported with Empagliflozin at a Single Veterans Affairs Health Care System
Favorite
12:00 PM – 1:00 PM
(3-173) Evaluation of Patients Admitted Through the Emergency Department for Low Risk Pulmonary Embolism
Favorite
12:00 PM – 1:00 PM
(3-174) Does Droperidol Work for Every Ailment? Droperidol for the Management of Phantom Limb Pain: A Case Report
Favorite
12:00 PM – 1:00 PM
(3-175) Impact of Patient Demographics and Social History on Propofol Dosing for Procedural Sedation in the Emergency Department
Favorite
12:00 PM – 1:00 PM
(3-176) Comparison of Hepatitis C Treatment Outcomes Between Transplant and Non-Transplant Patients
Favorite
12:00 PM – 1:00 PM
(3-177) Antimicrobial Management of Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia Complicated by Myocardial Abscess and an Infected Coronary Stent
Favorite
12:00 PM – 1:00 PM
(3-178) Characterization of Trends in Infectious Diseases Service Referrals to Outpatient Parenteral Antimicrobial Therapy (OPAT) Team with a Focus on Patient Eligibility and Outcomes
Favorite
12:00 PM – 1:00 PM
(3-179) Novel Pharmacogenetics Mobile Application as an Educational Intervention for Patients and Providers
Favorite
12:00 PM – 1:00 PM
(3-180) Assessing Appropriate Initiation of Parenteral Nutrition in Patients Admitted to a Community Health System
Favorite
12:00 PM – 1:00 PM
(3-181) Perioperative Management of Hemophilia B
Favorite
12:00 PM – 1:00 PM
(3-182) Pharmacist’s Potential to Use Pharmacogenomics to Tailor Perioperative Pain Management
Favorite
12:00 PM – 1:00 PM
(3-183) Evaluation of Fentanyl Patch Use Among Prescribers at University of Louisville (UofL) Health
Favorite
12:00 PM – 1:00 PM
(3-184) Characterization of Awareness and Depth of Blockade During Neuromuscular Blockade Infusions in Children
Favorite
12:00 PM – 1:00 PM
(3-185) Use of Pharmacokinetic Monitoring to Assess Acute Kidney Injury Risk in Vancomycin and Piperacillin-Tazobactam Combination Therapy
Favorite
12:00 PM – 1:00 PM
(3-186) Mixed Methods Analysis of Memantine Misuse Trends Identified Through a Social Media Mining Method
Favorite
12:00 PM – 1:00 PM
(3-187) Correlation of Pharmacy School Grade Point Average (GPA) to Post-Graduate Year Two (PGY2) Interview Offer
Favorite
12:00 PM – 1:00 PM
(3-188) Adverse Drug Reactions Reported Following a Mandatory Formulary Conversion: Symbicort vs. Wixela
Favorite
12:00 PM – 1:00 PM
(3-189) Evaluation of Time to Treatment Among Specialty Medications Transferred to External Specialty Pharmacies
Favorite
12:00 PM – 1:00 PM
(3-190) Volume Loss in Liquid Medications Using Different Dispensing Configurations
Favorite
12:00 PM – 1:00 PM
(3-191) Evaluating a Rare Case of Bifidobacterium Bacteremia and Suspected Neurosyphilis
Favorite
12:00 PM – 1:00 PM
(3-192) Implementation of Team-Based Learning in Pharmacy School Courses: A Systematic Review
Favorite
12:00 PM – 1:00 PM
(3-193) Critical Care Residents' Perception of a Virtual Interview and Search Process and Its Impact on PGY2 Program Selection
Favorite
12:00 PM – 1:00 PM
(3-194) Treatment with Very Low Dose Nilotinib Due to Adverse Events Results in Prolonged Major Molecular Response
Favorite
12:00 PM – 1:00 PM
(3-195) Evaluation of Suspected Bacterial Sepsis Work-Up and Initial Antibiotic Therapy in a Pediatric Cardiac Intensive Care Unit
Favorite
12:00 PM – 1:00 PM
(3-196) Implementation of Indications on Meropenem Orders in the Electronic Medical Record to Improve Antibiotic Use
Favorite
12:00 PM – 1:00 PM
(3-197) Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants (DOACs) versus Warfarin in Obese and Morbidly Obese African American (AA) Patients
Favorite
12:00 PM – 1:00 PM
(3-198) Inhibition of Alpha-glucosidase by Aloe Vera Plant (Aloe Barbadensis Miller) as an Antidiabetic Mechanism of Action
Favorite
12:00 PM – 1:00 PM
(3-199) Continuation Rate of Newly Initiated Midodrine During Intensive Care at Hospital Discharge
Favorite
12:00 PM – 1:00 PM
(3-200) Present Perceptions of Mistrust in Medical Treatment and Vaccination Among African Americans During the COVID-19 Pandemic
Favorite
12:00 PM – 1:00 PM
(3-201) Perceived Role and Identity of Pharmacists and the Potential Impact on COVID-19 Vaccine Uptake Per Louisiana Region: A Prospective Cohort Study
Favorite
12:00 PM – 1:00 PM
(3-202) Designing and Testing the Knockdown Efficacy of siRNAs Specifically Targeting the ERα36 Isoform in HEK293T Cells That Stably Express ERα36-GFP
Favorite
12:00 PM – 1:00 PM
(3-203) Appropriate Use of Zoledronic Acid for Oncologic Indications
Favorite
12:00 PM – 1:00 PM
(3-204) Evaluation of Intravenous N-Acetylcysteine for the Treatment of Pediatric Acetaminophen Toxicity
Favorite
12:00 PM – 1:00 PM
(3-205) Evaluating Student Pharmacists’ Perceptions on Immunization Communication
Favorite
12:00 PM – 1:00 PM
(3-206) Barriers to Electronic Prescribing of Opioids
Favorite
12:00 PM – 1:00 PM
(3-207) Examining the Effects of the COVID-19 Pandemic on Mental Health Among First Year Pharmacy Students
Favorite
12:00 PM – 1:00 PM
(3-208) Pharmacists' Role in Improving Outcomes for Diabetic Neuropathy
Favorite
12:00 PM – 1:00 PM
(3-209) Evaluating Appropriate Statin Therapy in Diabetic Patients in Regards to Age, Smoking Status, A1c, and ASCVD Risk
Favorite
12:00 PM – 1:00 PM
(3-210) Stability of Multi-Ingredient Preparations Intended to Relieve Pain
Favorite
12:00 PM – 1:00 PM
(3-211) Continuation Rate of Newly Initiated Stress Ulcer Prophylaxis in the Intensive Care Unit at Discharge
Favorite
12:00 PM – 1:00 PM
(3-212) Medication Use Evaluation of Rasburicase for Tumor Lysis Syndrome (TLS) in Pediatric Oncology Patients
Favorite
12:00 PM – 1:00 PM
(3-213) Trends of COVID-19 Vaccination Among Louisiana Pharmacies from May 2021 to May 2022: A Prospective, Cohort Study
Favorite
12:00 PM – 1:00 PM
(3-214) Silmitasertib (CX-4945) Facilitates Proteasome-Mediated Degradation of Estrogen Receptor (ER) and Alters the Expression of a Panel of Genes Involved in Estrogen Receptor Signaling Pathway
Favorite
12:00 PM – 1:00 PM
(3-215) Assessing the Knowledge and Perceptions of Coronavirus Disease-19 (COVID-19) Vaccines Among Fourth Year Student Pharmacists
Favorite
12:00 PM – 1:00 PM
(3-216) Continuation Rate of Newly Initiated Propranolol in the Intensive Care Unit at Hospital Discharge
Favorite
12:00 PM – 1:00 PM
(3-217) Evaluation of Durations of Discharge Antibiotic Prescriptions for Community-Acquired Pneumonia
Favorite
12:00 PM – 1:00 PM
(3-218) Compensation for State Board of Pharmacy Members
Favorite
12:00 PM – 1:00 PM
(3-219) Metformin Reduces Atypical Antipsychotic-Associated Weight Gain in Adults
Favorite
12:00 PM – 1:00 PM
(3-220) Collaboration Across Specialties in a Pharmacists Led Pharmacogenomic Initiative Within a Community Health-System
Favorite
12:00 PM – 1:00 PM
(3-221) Continuous Glucose Monitoring and Effects on HbA1c in Patients Diagnosed with Type 2 Diabetes
Favorite
12:00 PM – 1:00 PM
(3-222) Evaluation of in Vitro Antimicrobial Resistance Selection in Salmonella Enterica Serovar Typhi (Salmonella Typhi)
Favorite
12:00 PM – 1:00 PM
(3-223) Evaluation of a Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab Protocol
Favorite
12:00 PM – 1:00 PM
(3-224) Collaborative Practice Agreement for Chemotherapy-Induced Nausea and Vomiting: Pharmacist Impact on National Guideline Compliance and Patient Outcomes
Favorite
12:00 PM – 1:00 PM
(3-225) Evaluation of Appropriateness of Guideline Directed Medical Therapy in Chronic Heart Failure Patients Admitted to Observational Unit in a Community Hospital
Favorite
12:00 PM – 1:00 PM
(3-226) Medication Management Clinic Participation in Discharge Rounds Improves Resolution of Medication Cost Barriers Prior to Discharge in a Community Hospital
Favorite
12:00 PM – 1:00 PM
(3-227) Correlation of PHQ-9 Scores with HIV Outcomes Before and During the COVID-19 Pandemic
Favorite
12:00 PM – 1:00 PM
(3-228) Selecting a Glucagon-Like Peptide- 1 Receptor Agonist versus Sodium-Glucose Co-Transporter-2 Inhibitor for Secondary Prevention of Major Cardiovascular Events Post-Stroke
Favorite
12:00 PM – 1:00 PM
(3-229) Evaluation of Guideline Driven Heparin Induced Thrombocytopenia Antibody Testing Within a Health System
Favorite
12:00 PM – 1:00 PM
(3-231) Assessing Effects of Cannabis, Cannabinoids and Their Metabolites on the Pharmacokinetics of Antiretroviral Therapy (ART)
Favorite
12:00 PM – 1:00 PM
(3-232) Analysis of Pharmacist’s Understanding of Oral Health/Denture Management and Its Impact on Patient Outcomes
Favorite
12:00 PM – 1:00 PM
(3-233) Assessing the Effects of Antibiotics on the Gut Microbiome
Favorite
12:00 PM – 1:00 PM
(3-234) Effects of COVID-19 Pandemic on Spirituality and Resilience in Health Professional Students
Favorite
12:00 PM – 1:00 PM
(3-235) Retrospective Review of the Safety and Efficacy of Using IV/IM Droperidol in a Community Hospital Emergency Department
Favorite
12:00 PM – 1:00 PM
(3-236) Impact of a Pharmacy Integration in Discharge Rounds on Addressing Medication Discrepancies Prior to Discharge and Readmissions at a Community Hospital
Favorite
12:00 PM – 1:00 PM
(3-237) Missed Opportunities for Optimization of Cholesterol Management in Clinical Atherosclerotic Cardiovascular Disease
Favorite
12:00 PM – 1:00 PM
(3-238) Prophylactic Amiodarone Use in the Management of Postoperative Atrial Fibrillation at Luminis Health Anne Arundel Medical Center
Favorite
12:00 PM – 1:00 PM
(3-239) Evaluation of Intensities of Anticoagulation for Thromboprophylaxis in Coronavirus Disease 2019 (COVID-19) Infected Intensive Care Unit (ICU) Patients
Favorite
12:00 PM – 1:00 PM
(3-240) Review of Accelerate-Pheno Implementation and De-Escalation for Bacteremia at MedStar Union Memorial Hospital and MedStar Good Samaritan Hospital
Favorite
12:00 PM – 1:00 PM
(3-241) Evaluating Outpatient Vancomycin Monitoring and the Incidence of Nephrotoxicity
Favorite
12:00 PM – 1:00 PM
(3-242) Retrospective Chart Review of De-Escalation of Vasopressin in Patients with Septic Shock
Favorite
12:00 PM – 1:00 PM
(3-243) Anti-obesity Weight Loss Medications: Short-term and Long-term Use
Favorite
12:00 PM – 1:00 PM
(3-244) Evaluation of Drug Delivery Efficacy in Neuroblastoma Using in Vitro Models
Favorite
12:00 PM – 1:00 PM
(3-245) Evaluation of Fibrinolytic-associated Adverse Drug Events in Acute Ischemic Stroke
Favorite
12:00 PM – 1:00 PM
(3-246) Comprehensive Pharmacist-led Transitions-of-care Medication Management Intervention for Older Adults Around Hospital Discharge: A Time-and-Motion Analysis of Resources and Costs
Favorite
12:00 PM – 1:00 PM
(3-247) Assessing the Impact of Social Determinants of Health in Patients with Opioid Use Disorder in the Primary Care Setting
Favorite
12:00 PM – 1:00 PM
(3-248) Enoxaparin Anti-Xa Monitoring in Obese Patients with Acute Venous Thromboembolism
Favorite
12:00 PM – 1:00 PM
(3-249) Systematic Review and Bayesian Network Meta-analysis of Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors on Cardiovascular Outcomes
Favorite
12:00 PM – 1:00 PM
(3-250) Nirmatrelvir/ritonavir Drug Interactions : What Should We Know?
Favorite
12:00 PM – 1:00 PM
(3-251) Change in Invasive Hemodynamic Markers with Use of Intravenous Octreotide in a Patient with Pulmonary Hypertension: A Case Report
Favorite
12:00 PM – 1:00 PM
(3-252) Novel Uses of Ketamine
Favorite
12:00 PM – 1:00 PM
(3-254) Effect of Sotrovimab on Hospitalization, Mortality, and COVID-19 Progression in High Risk Outpatients: An Exploratory Meta-analysis
Favorite
12:00 PM – 1:00 PM
(3-255) Concern for Resistance to Pneumocystis Jiroveci Pneumonia Case Report
Favorite
12:00 PM – 1:00 PM
(3-256) Utility of Ursodiol for SOS/VOD Prophylaxis in Acute Leukemia Patients Receiving Gemtuzumab-Ozogamicin (GO) or Inotuzumab-Ozogamicin (InO)
Favorite
12:00 PM – 1:00 PM
(3-257) Inhibitory Effect of SCH-79797 on Cell Proliferation of the A549 Lung Adenocarcinoma Cell Line
Favorite
12:00 PM – 1:00 PM
(3-259) Assessing the Effectiveness of Rapid PCR Testing in Decreasing Time to De-escalation for Staphylococcus aureus Bacteremia in a Community Hospital
Favorite
12:00 PM – 1:00 PM
(3-260) Characterization of Extravasation Events from Peripherally Administered Vasopressors at a Community Hospital
Favorite
12:00 PM – 1:00 PM
(3-261) Evaluation of Patients’ Satisfaction and Preferences in Telemental Health Services: A Survey Study
Favorite
12:00 PM – 1:00 PM
(3-262) Transition to Once Weekly Tirzepatide After Severe Nausea and Vomiting One Year After Successful Treatment with Both Semaglutide and Exenatide LAR Once Weekly
Favorite
12:00 PM – 1:00 PM
(3-263) Pravastatin for Radiation-Induced Fibrosis Pain
Favorite
12:00 PM – 1:00 PM
(3-264) Evaluating Health Outcomes Associated with Concordant Language Interactions Between Diabetic Hispanic Patients and Providers
Favorite
12:00 PM – 1:00 PM
(3-265) Comparing Geographical Disparities of COVID-19 Vaccines: Evaluation of Rural vs Urban Areas
Favorite
12:00 PM – 1:00 PM
(3-266) Dysregulated Biological Processes in Pancreatic Ductal Adenocarcinoma Cancer (PDAC) Patients Treated with FOLFIRINOX as Standard Chemotherapy
Favorite
12:00 PM – 1:00 PM
(3-267) Pancreatic Cancer: Tumor Location and Likelihood of Diabetes as a Comorbidity
Favorite
12:00 PM – 1:00 PM
(3-268) Analyzing the Effectiveness of Social Stories for Behavioral Modifications in Autistic Children and Its Applicability in the Pharmacy Setting
Favorite
12:00 PM – 1:00 PM
(3-269) Social Stories for Targeting Medication Adherence and Tolerability in Pediatric Patients with ASD
Favorite
12:00 PM – 1:00 PM
(3-270) Pharmacogenomic Review of the Clinical Implications of CYP2B6 Polymorphisms on Methadone Therapy
Favorite
12:00 PM – 1:00 PM
(3-271) Differentially Expressed Genes in Subtypes of Pancreatic Ductal Adenocarcinoma and Beta Cell Development
Favorite
12:00 PM – 1:00 PM
(3-272) Efficacy of Drug Combination Regimens of Vancomycin or Daptomycin with Beta-lactam Antibiotics for Methicillin-resistant Staphylococcus aureus Infections
Favorite
12:00 PM – 1:00 PM
(3-273) Management of Carfilzomib-Induced Thrombotic Microangiopathy
Favorite
12:00 PM – 1:00 PM
(3-274) Hydrochlorothiazide-Induced Pulmonary Edema: Case Report
Favorite
12:00 PM – 1:00 PM
(3-275) Evaluating Use of Intranasal Esketamine in Treatment-Resistant Major Depressive Disorder (MDD) Treated Adjunctively with Oral Antidepressant
Favorite
12:00 PM – 1:00 PM
(3-276) Specialty Medication Utilization Project: Upadacitinib for the Treatment of Rheumatoid Arthritis
Favorite
12:00 PM – 1:00 PM
(3-277) Examining the Association Between COVID-19 Infection and Worsening Diabetes Mellitus
Favorite
12:00 PM – 1:00 PM
(3-278) The Opioid Epidemic and the Forgotten Population
Favorite
12:00 PM – 1:00 PM
(3-279) The Effectiveness of Pharmacist Telemedicine Services
Favorite
12:00 PM – 1:00 PM
(3-280) Utilization of Targeted Nanoparticles to Improve Therapeutic Outcomes in Management of Retinoblastoma
Favorite
12:00 PM – 1:00 PM
(3-281) BCMA in Vitro Assays to Evaluate Nanotherapeutics for Multiple Myeloma Treatment
Favorite
12:00 PM – 1:00 PM
(3-282) Finerenone and Empagliflozin Use for Chronic Kidney Disease with Albuminuria in a Patient with Type 2 Diabetes and Hypertension
Favorite
12:00 PM – 1:00 PM
(3-283) The Effects of Hypertension on Patients from a Low-income Population
Favorite
12:00 PM – 1:00 PM
(3-284) Comparing Community Hospital Protocols and National Institutes of Health Guidelines Regarding the Use of Interleukin-6 Inhibitors in Hospitalized COVID-19 Patients
Favorite
12:00 PM – 1:00 PM
(3-286) Targeted Therapy for Malignant Rhabdoid Tumors via SMARCB1-Mutation Mediated Pathways
Favorite
12:00 PM – 1:00 PM
(3-287) Case Report of Possible Bloating and Abdominal Pain After a Manufacturer Change of Dextroamphetamine Tablets in a Patient with Celiac Disease
Favorite
12:00 PM – 1:00 PM
(3-288) Biopharmaceutical and Digital Health Partnerships on Promoting Adherence to Diabetes Medications
Favorite
12:00 PM – 1:00 PM
(3-289) Tocilizumab Treatment: A Potential New Option for Scleroderma Patients
Favorite
12:00 PM – 1:00 PM
(3-290) Safety and Efficacy Analysis of High-Dose Methotrexate Use in Adult Patients with High-Grade Primary Osteosarcoma: A Systematic Review
Favorite
12:00 PM – 1:00 PM
(3-291) Where to Go When You Need to Know?: A Meds to Beds Tool to Improve Visibility of Order Progress
Favorite
12:00 PM – 1:00 PM
(3-292) Design, Synthesis, and Assay of Novel Compounds for the Treatment of Chagas Disease
Favorite
12:00 PM – 1:00 PM
(3-293) Efficacy of a Digoxin Load Order Panel for Atrial Fibrillation or Flutter with Rapid Ventricular Response
Favorite
12:00 PM – 1:00 PM
(3-294) Inappropriate DOAC Dosing in Older Adults and Clinical Outcomes
Favorite
12:00 PM – 1:00 PM
(3-295) Paliperidone Induced Hepatotoxicity in a 61-year-old Patient
Favorite
12:00 PM – 1:00 PM
(3-296) Droperidol and QTc Prolongation in the Emergency Department: A Retrospective Observational Study
Favorite
12:00 PM – 1:00 PM
(3-297) Review of Antiretroviral Stewardship Practices at a Tertiary Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-298) Implementation of a Longitudinal Pharmacy Student Patient Education Service Pilot at a Large Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-299) Evaluation of National Practices for PGY1 Pharmacy Residency Emergency Response
Favorite
12:00 PM – 1:00 PM
(3-300) InsPIRe-Me: Industry Pharmacy Initiative for PharmD Students to Reach Their Goals Through Fellow Mentorship
Favorite
12:00 PM – 1:00 PM
(3-301) Rate of Adherence to Lamotrigine Titration Schedules with or Without Drug-Drug Interactions at an Inpatient Psychiatric Facility
Favorite
12:00 PM – 1:00 PM
(3-302) Pharmacogenomic Testing in Patients with Major Depressive Disorder: Global versus U.S. Perspective
Favorite
12:00 PM – 1:00 PM
(3-303) Impact of Polypharmacy on Time in Therapeutic Range for Older Adults with Atrial Fibrillation Taking Warfarin
Favorite
12:00 PM – 1:00 PM
(3-304) Evaluation of the Safety of Inpatient Utilization of Empagliflozin
Favorite
12:00 PM – 1:00 PM
(3-305) Impact of Overlapping Cognitive Impairment and Physical Frailty on Oral Anticoagulant Therapy Outcomes in Older Atrial Fibrillation Patients
Favorite
12:00 PM – 1:00 PM
(3-306) Overview of Direct-to-Consumer Pharmacies and Their Role in Pharmacy Practice
Favorite
12:00 PM – 1:00 PM
(3-307) Systematic Review of the Effectiveness of Telepharmacy Services in Ambulatory and Community Pharmacy
Favorite
12:00 PM – 1:00 PM
(3-308) Optimizing Heart Failure Guideline Directed Medical Therapy Utilization by Enhancing Transitions of Care
Favorite
12:00 PM – 1:00 PM
(3-309) Effect of Pharmacist-Led Interventions on Diabetes Distress Among People with Type 2 Diabetes in a Community Care Setting
Favorite
12:00 PM – 1:00 PM
(3-310) Effect of Combination Therapy with Ceftaroline versus Standard of Care on Time to Clearance of Persistent Methicillin Resistant Staphylococcus aureus Bacteremia
Favorite
12:00 PM – 1:00 PM
(3-311) Evaluation of Azithromycin Dosing Regimens at an Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-312) Prophylactic Use of Oral Vancomycin in Hospitalized Patients at Risk for C. Difficile
Favorite
12:00 PM – 1:00 PM
(3-313) Exploring the Pharmacist’s Role in the Future of Technology in the Healthcare System
Favorite
12:00 PM – 1:00 PM
(3-314) Optimizing the Potential of Zafirlukast as an Antithrombotic Agent Through the Creation of Second-generation Analogs
Favorite
12:00 PM – 1:00 PM
(3-230) A System Wide Approach to Addressing Practical Challenges in Continuing Glucagon-Like Peptide-1 Receptor Agonists During Hospitalization
Favorite
12:00 PM – 1:00 PM
(3-010) 2020 Heart Disease Deaths Compared to Medicare Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease Inhibitor (PCSK9i) Prescription Rates
Favorite
12:00 PM – 1:00 PM
(3-285) A Review of the Safety and Efficacy of Long-Acting Cabotegravir Intramuscular Injection for Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis
Favorite
4:15 PM – 5:15 PM
(5-059) A Medical Use Evaluation for Clostridioides difficile Infection Treatments at a Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-255) A Systematic Review of Emerging Alternative Payment Models (APMs) Used for Oncologic Treatment in the United States
Favorite
4:15 PM – 5:15 PM
(5-001) Assessing the Impact of Pharmacist-Initiated Staphylococcus Aureus Nasal PCR Protocol on Vancomycin Use in Non-purulent Cellulitis
Favorite
4:15 PM – 5:15 PM
(5-002) Assessment of Comprehensive Medication Management Incorporating a Patient Self-completed Medical/Medication Form
Favorite
4:15 PM – 5:15 PM
(5-003) Novel Beta-Lactam/Beta-Lactamase Inhibitor Combination Use in Morbidly Obese Patients with Pseudomonas Aeruginosa Pneumonia: Multicenter Evaluation of Clinical and Safety Endpoints
Favorite
4:15 PM – 5:15 PM
(5-004) Oncologic Maintenance Therapies in Progression-Free Populations: A Systematic Literature Review
Favorite
4:15 PM – 5:15 PM
(5-005) Implementation of a Primary Care Opioid Stewardship Team Reduces Morphine Milligram Equivalents in Patients on Chronic, High-Dose Opioid Therapy
Favorite
4:15 PM – 5:15 PM
(5-006) Retrospective Chart Review Comparing Safety and Efficacy of Direct Oral Anticoagulants versus Warfarin in Patients Diagnosed with Liver Impairment
Favorite
4:15 PM – 5:15 PM
(5-007) Infectious Diagnoses and Antibiotic Concordance Compared Between White and Non-White Populations Within Three Michigan Health Systems
Favorite
4:15 PM – 5:15 PM
(5-008) Telemedicine Antibiotic Prescribing Trends Pre and Post COVID-19 Pandemic in Michigan
Favorite
4:15 PM – 5:15 PM
(5-009) Impact of a Less Time Intensive Leadership Development Elective on Pharmacy Students
Favorite
4:15 PM – 5:15 PM
(5-010) Differences in the Approach to Guideline Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction: A Survey of Cardiologists, Internists, and Pharmacists
Favorite
4:15 PM – 5:15 PM
(5-011) Human Papillomavirus (HPV) Vaccination: First-Year College Students' Beliefs & Attitudes
Favorite
4:15 PM – 5:15 PM
(5-012) Use of Infliximab in Patients with Liver Dysfunction for the Treatment of Immune Checkpoint Inhibitor Toxicity
Favorite
4:15 PM – 5:15 PM
(5-013) Evaluation of the Use of Novel Agents for Sickle Cell Disease at an Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-014) Treating Prehospital Pain in Children: A Retrospective Chart Review Comparing the Safety and Efficacy of Prehospital Pediatric Ketamine and Opiate Analgesia
Favorite
4:15 PM – 5:15 PM
(5-015) Clinical Impact of a Heparin Nomogram in a Pediatric Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-016) Frequency of Possible Interactions Between Cannabis and Prescribed Psychotropics
Favorite
4:15 PM – 5:15 PM
(5-018) Adverse Drug Reactions and CYP2C19 Phenotype in SSRI Treated Patients with Neurodevelopmental Disorders
Favorite
4:15 PM – 5:15 PM
(5-019) Impact of Rurality and Age on Colorectal Cancer Screening Rates Among Michigan Residents
Favorite
4:15 PM – 5:15 PM
(5-021) Phage-Antibiotic Combinations Against Multidrug-resistant S. Aureus and E. Faecium: Protein Synthesis Inhibitors Antagonize Phage Activity
Favorite
4:15 PM – 5:15 PM
(5-022) Effectiveness of Etelcalcetide After Cinacalcet in End Stage Kidney Disease Hemodialysis Patients
Favorite
4:15 PM – 5:15 PM
(5-023) Sequential Dosing of Phage-Antibiotic Combinations in MDR Pseudomonas Aeruginosa
Favorite
4:15 PM – 5:15 PM
(5-024) High Definition Pharmacogenomics and Therapeutics for CYP3A4 and CYP3A5
Favorite
4:15 PM – 5:15 PM
(5-025) Evaluation of Differences in Payer-negotiated Prices Between Biosimilars and Originator Drugs
Favorite
4:15 PM – 5:15 PM
(5-026) Enhancing Resident-Preceptor Relationships Through Resilience Discussions
Favorite
4:15 PM – 5:15 PM
(5-027) Resident Physician Perceptions, Expectations, and Experiences with Ambulatory Care Pharmacists and the Services Provided in Outpatient Clinics at a Large Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-028) Ticagrelor-Induced Syncope in Bradycardic Patient
Favorite
4:15 PM – 5:15 PM
(5-029) Serotonin Syndrome: Medication Reconciliation Pitfalls and Novel Risks
Favorite
4:15 PM – 5:15 PM
(5-030) Comparison of Insulin 5 Units versus 10 Units for the Management of Hyperkalemia
Favorite
4:15 PM – 5:15 PM
(5-031) High Dose Amphotericin Use in Various Fungal and Fungal-Related Infections
Favorite
4:15 PM – 5:15 PM
(5-032) Methicillin-Susceptible Staphylococcus aureus COVID-19 Superinfection: A Case Series
Favorite
4:15 PM – 5:15 PM
(5-033) Effect of Inappropriate Surgical Prophylactic Regimens on Surgical Site Infections in Intra-abdominal Surgeries
Favorite
4:15 PM – 5:15 PM
(5-034) Evaluation of a Pediatric Enoxaparin Dosing Protocol at Children’s of Mississippi
Favorite
4:15 PM – 5:15 PM
(5-035) Evaluation of Guideline Directed Pharmacotherapy in the Pediatric Hypertension Clinic
Favorite
4:15 PM – 5:15 PM
(5-036) Evaluating the Impact of Coronavirus Disease of 2019 (COVID-19) on Learning Opportunities and Communication Readiness in Introductory Pharmacy Practice Experience (IPPE) Students
Favorite
4:15 PM – 5:15 PM
(5-037) Evaluation of a Pediatric Community-Acquired Pneumonia Antimicrobial Stewardship Intervention at an Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-038) Design and Development of New Dehli Metallo-β-Lactamase 1 Inhibitors to Combat Antibiotic-Resistant Bacteria
Favorite
4:15 PM – 5:15 PM
(5-039) Incidence and Management of Cytokine Release Syndrome and Neurotoxicity in Acute Lymphoblastic Leukemia Patients with Minimal Residual Disease Receiving Blinatumomab
Favorite
4:15 PM – 5:15 PM
(5-040) Adherence to Institutional Antimicrobial Dosing for Intensive Care Unit Patients on Continuous Renal Replacement Therapy
Favorite
4:15 PM – 5:15 PM
(5-041) Sodium Zirconium Cyclosilicate Utilization for Acute Hyperkalemia at an Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-042) Retrospective Observational Cohort Study Evaluating the Use and Risks of Opioid Therapy in Patients Receiving Rehabilitation Treatment
Favorite
4:15 PM – 5:15 PM
(5-043) Impact of Pharmacist-Driven Messaging to Improve Guideline Directed Medical Therapy (GDMT) in Heart Failure with Reduced Ejection Fraction (HFrEF) Patients
Favorite
4:15 PM – 5:15 PM
(5-044) Evaluation of Prescribing Patterns for Sodium-Glucose Cotransporter Protein 2 (SGLT2) Inhibitors in a Primary Care Medicine Clinic
Favorite
4:15 PM – 5:15 PM
(5-045) Assessing the Use of Baricitinib as Treatment for Hospitalized Patients with COVID-19
Favorite
4:15 PM – 5:15 PM
(5-046) Evaluation of Automated Dispensing Cabinet Override Medication Use Within an Academic Health System
Favorite
4:15 PM – 5:15 PM
(5-047) Treatment Outcomes in Advanced Cancer Patients Receiving Immune Checkpoint Inhibitors and Concurrent Proton Pump Inhibitor Therapy
Favorite
4:15 PM – 5:15 PM
(5-048) Evaluating the Readability of Patient Level Educational Materials on Biosimilars Used in a Rheumatology Clinic
Favorite
4:15 PM – 5:15 PM
(5-049) Medication Use Evaluation of Undiluted Sodium Bicarbonate Continuous Infusions in Critically Ill Patients
Favorite
4:15 PM – 5:15 PM
(5-050) Therapeutic Interchange of Rifaximin in Acute Overt Hepatic Encephalopathy
Favorite
4:15 PM – 5:15 PM
(5-051) Impact of a Student Pharmacist Led Medication Counseling Program for Patients with Heart Failure in a Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-052) Evaluating Early Use of Front-Loading Phenobarbital in Patients with Alcohol Withdrawal
Favorite
4:15 PM – 5:15 PM
(5-053) Evaluation of Hypoglycemia Incidence and Associated Risk Factors in Patients Treated with Intravenous Insulin for Acute Hyperkalemia Management
Favorite
4:15 PM – 5:15 PM
(5-054) Outcomes of a Mini-Desensitization Protocol with Docetaxel, Paclitaxel, or Carboplatin
Favorite
4:15 PM – 5:15 PM
(5-055) Neonatal Gentamicin Concentrations Following Maternal Once-Daily Gentamicin Dosing
Favorite
4:15 PM – 5:15 PM
(5-056) Treatment Evaluation of Uncomplicated Cystitis Infections
Favorite
4:15 PM – 5:15 PM
(5-057) Evaluating the Need for Standardized Electrolyte Management by Means of a Phosphorus Replacement Protocol in a Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-058) Standardization of Oral Solution Naming for the Prevention of Medication-Related Dosing Errors upon Order Verification and Administration
Favorite
4:15 PM – 5:15 PM
(5-060) Reduction in Monthly Migraine Days in Patients Prescribed Galcanezumab versus Erenumab
Favorite
4:15 PM – 5:15 PM
(5-061) Fixed Rate vs. Variable Rate Continuous Insulin Infusion Regimens for the Treatment of Hypertriglyceridemia-Induced Pancreatitis
Favorite
4:15 PM – 5:15 PM
(5-062) Alvimopan Utilization Analysis: Opportunities for Pharmacist Intervention in a Large Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-063) Retrospective Comparison of Vitamin B12 Intramuscular Injection Administration Prior to Pemetrexed in Non-Small Cell Lung Cancer and Malignant Mesothelioma
Favorite
4:15 PM – 5:15 PM
(5-064) Analysis of a Cystic Fibrosis-Specific Antibiogram Before and After FDA Approval of Elexacaftor/Tezacaftor/Ivacaftor (ETI)
Favorite
4:15 PM – 5:15 PM
(5-065) Evaluation of Hypertonic Saline Use Outside of the Intensive Care Unit
Favorite
4:15 PM – 5:15 PM
(5-066) Pharmacist Involvement in the Perioperative Management of Antirheumatic Medication in a Rheumatology Clinic
Favorite
4:15 PM – 5:15 PM
(5-067) Improving Community Pharmacist Climate Change Involvement in Montana
Favorite
4:15 PM – 5:15 PM
(5-068) Extended Use of Crotalidae Polyvalent Immune FAB (Ovine) Beyond 18-Hours
Favorite
4:15 PM – 5:15 PM
(5-069) Potential Benefit of Baclofen in Tapering Phenibut
Favorite
4:15 PM – 5:15 PM
(5-070) Medication Use Evaluation: Cholesterol Lowering Medication Optimization in Patients with Very High Risk ASCVD
Favorite
4:15 PM – 5:15 PM
(5-071) Evaluation of Albumin Use in Patients with Ascites Secondary to Cirrhosis
Favorite
4:15 PM – 5:15 PM
(5-072) Drug Use Evaluation: Trauma Dosing of Prophylactic Enoxaparin at St. Vincent Hospital
Favorite
4:15 PM – 5:15 PM
(5-073) Evaluation of Loop Diuretic Use in Hospitalized Adult Acute Decompensated Heart Failure (ADHF) Patients
Favorite
4:15 PM – 5:15 PM
(5-074) Treatment of Open Fractures: Review of Emergency Department Pharmacists' Impact on Antibiotic Administration
Favorite
4:15 PM – 5:15 PM
(5-075) Assessing Patient Controlled Analgesia Use in a Community Hospital Setting
Favorite
4:15 PM – 5:15 PM
(5-076) Evaluation of the Body-Weight Method in Predicting Lithium Concentrations in a Pediatric Population
Favorite
4:15 PM – 5:15 PM
(5-077) Evaluating High Dose Olanzapine in a Morbidly Obese Patient Using Therapeutic Drug Monitoring
Favorite
4:15 PM – 5:15 PM
(5-078) Combining Nirmatrelvir/Ritonavir with Nifedipine: A Cytochrome P450 3A4 Drug Interaction Case Report
Favorite
4:15 PM – 5:15 PM
(5-079) Development of a Formal Assessment to Guide Acute Agitation Medication Administration for Use on an Inpatient Adult Psychiatric Unit
Favorite
4:15 PM – 5:15 PM
(5-080) Cannabis Use Among Oncology Patients: Does the Patient Chart Documentation Always Report on Current Use of Cannabis Product?
Favorite
4:15 PM – 5:15 PM
(5-081) Sugammadex Medication Use Evaluation: A Retrospective Cohort Study of Recovery Following Perioperative Aminosteroid Neuromuscular Blockade
Favorite
4:15 PM – 5:15 PM
(5-082) Evaluation of Pharmacist-Led Intervention to Improve Access to Glucagon Emergency Devices
Favorite
4:15 PM – 5:15 PM
(5-083) Characterization and Evaluation of Medications Dispensed in Rural Villages Served During an International APPE in the Dominican Republic
Favorite
4:15 PM – 5:15 PM
(5-084) Inhaled Corticosteroid Use in Patients Admitted with Chronic Obstructive Pulmonary Disease Exacerbation Without Prior Maintenance Therapy at an Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-085) Rituximab Induced Pulseless Electrical Activity
Favorite
4:15 PM – 5:15 PM
(5-086) Midodrine Utilization Evaluation for Hypotension in the Intensive Care Unit
Favorite
4:15 PM – 5:15 PM
(5-087) Evaluation of IV Fentanyl Infusion Dose in the Intensive Care Unit
Favorite
4:15 PM – 5:15 PM
(5-088) Erythropoietin Stimulating Agents: Drug Utilization Evaluation at Mount Auburn Hospital
Favorite
4:15 PM – 5:15 PM
(5-089) Pseudomonas Aeruginosa Bacteremia and Patient Outcome
Favorite
4:15 PM – 5:15 PM
(5-090) Syncopal Episode After Ingestion of Bowel Cleansing Preparation, Polyethylene Glycol 3350, for Colonoscopy Procedure
Favorite
4:15 PM – 5:15 PM
(5-091) Effect of Desmopressin Administration for Antiplatelet Reversal in Patients with Traumatic Intracranial Hemorrhage
Favorite
4:15 PM – 5:15 PM
(5-092) Can Financial Well-Being Be Improved in Low-Income Patients Without Increasing Salary? Findings from a Financial Education and Coaching Intervention
Favorite
4:15 PM – 5:15 PM
(5-093) Analysis of the Rate of Neonatal Intensive Care Unit Admissions When Non-Group B Streptococcus Specific Intrapartum Antibiotics Are Utilized
Favorite
4:15 PM – 5:15 PM
(5-094) Impact of a Student Pharmacist-Led Initiative to Improve Statin Use in Diabetes
Favorite
4:15 PM – 5:15 PM
(5-095) Analysis of Pre-Evaluation Use of Dementia Medications in Patients Undergoing Comprehensive Geriatric Assessment (CGA) for Cognitive Symptoms
Favorite
4:15 PM – 5:15 PM
(5-096) Cost Effectiveness Analysis of Pharmacist Intervention versus Usual Care in the Management of Osteoporosis
Favorite
4:15 PM – 5:15 PM
(5-097) Assessment of Current Phenytoin Dosing and Monitoring Patterns
Favorite
4:15 PM – 5:15 PM
(5-098) Assessment of the Implementation of a Heparin Bolus Nomogram for Percutaneous Coronary Intervention to Improve Time to Goal Activated Clotting Time: A Subgroup Analysis
Favorite
4:15 PM – 5:15 PM
(5-099) C1 Esterase Inhibitor for the Off-Label Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
Favorite
4:15 PM – 5:15 PM
(5-100) Exploring the Effects of Cisplatin-Topotecan Combination Therapy on Cisplatin-Resistant Cervical Cancer HeLa Cells
Favorite
4:15 PM – 5:15 PM
(5-101) Predicting Substitutes for Doxorubicin Within the FAC and TAC Chemotherapeutic Regimens by Looking at Gene Regulation Similarities and Differences
Favorite
4:15 PM – 5:15 PM
(5-102) Assessing the Impact, in a Three-year Doctorate Pharmacy Program, of Additional End-of-day Quizzes in Student’s Attendance and Performance in Routine Quizzes Held the Following Day
Favorite
4:15 PM – 5:15 PM
(5-105) Exploring Nucleolin-G Protein Coupled Receptor Kinase 5 Interactions in Cisplatin Resistant Cervical Cancer Cells
Favorite
4:15 PM – 5:15 PM
(5-106) Utilizing Caenorhabditis Elegans as an Experimental Model to Predict Toxicity of Various Antidepressants
Favorite
4:15 PM – 5:15 PM
(5-107) Impact of Virtual Learning During the COVID-19 Pandemic on Pharmacy Students' Perceived Learning and Wellbeing
Favorite
4:15 PM – 5:15 PM
(5-108) Exploring the Effects of G Protein Coupled Receptor Kinase 2 and Beta Arrestin 2 on the Efficacy of the TAC Regimen
Favorite
4:15 PM – 5:15 PM
(5-110) Retrospective Medication Use Evaluation of Antiretrovirals for Human Immunodeficiency Virus During Hospitalization
Favorite
4:15 PM – 5:15 PM
(5-111) Exploring the Influence of Chlorpromazine Using Caenorhabditis Elegans as an Experimental Model
Favorite
4:15 PM – 5:15 PM
(5-112) Exploring Octopamine Activity Using Caenorhabitis Elegans as an Experimental Model
Favorite
4:15 PM – 5:15 PM
(5-113) Utilizing a Bioinformatic Approach for Identifying New G-Protein Coupled Receptor Kinase 5 Interacting Proteins - What Can We Learn from What Is Known?
Favorite
4:15 PM – 5:15 PM
(5-114) Investigating the Effects of Amlexanox in Combination with Cisplatin on Cervical Cancer Cells
Favorite
4:15 PM – 5:15 PM
(5-115) Exploring Adrenergic Receptor Antagonists Using Caenorhabditis Elegans as an Experimental Model
Favorite
4:15 PM – 5:15 PM
(5-116) Evaluation of Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitor Prescribing Patterns in Heart Failure Patients at Hospital Discharge
Favorite
4:15 PM – 5:15 PM
(5-117) Non-FDA Approved Nutraceuticals: An Evaluation of Structure and Function Memory Claims
Favorite
4:15 PM – 5:15 PM
(5-118) Retrospective Analysis of Clinical Outcomes Associated with Fluid Resuscitation in Sepsis or Septic Shock Based on Ideal Body Weight
Favorite
4:15 PM – 5:15 PM
(5-119) Naloxone Prescribing at Emergency Department Discharge After Opioid Overdose
Favorite
4:15 PM – 5:15 PM
(5-120) Retrospective Analysis of Adverse Effects Associated with Intravenous Insulin Infusions for Patients with Diabetic Ketoacidosis
Favorite
4:15 PM – 5:15 PM
(5-121) Evaluating Virologic Suppression Before, During, and After Pregnancy Among Women with Human Immunodeficiency Virus (HIV)
Favorite
4:15 PM – 5:15 PM
(5-122) Influencer Pharmaceutical Marketing: A Review of Food and Drug Administration (FDA) Warning and Untitled Letters
Favorite
4:15 PM – 5:15 PM
(5-123) Global Drug Shortages and Impact of COVID-19: Readiness Parameters and Best Practices
Favorite
4:15 PM – 5:15 PM
(5-124) Five Year Retrospective Analysis of Neurological Scales Used in Adult Clinical Trials for Major Depressive Disorder
Favorite
4:15 PM – 5:15 PM
(5-125) Wellness Program and Social Media Utilization by Pharmacy Residency Programs in the Tri-state Area and Comparisons to Medical Residency Programs
Favorite
4:15 PM – 5:15 PM
(5-126) Financial Impact Associated with Retrospective Implementation of Standardized Dose Rounding for Biologic and Cytotoxic Antineoplastic Agents
Favorite
4:15 PM – 5:15 PM
(5-127) Historical Analysis of Select Checkpoint Inhibitors in Clinical Trials and Guidelines for Non-Small Cell Lung Cancer
Favorite
4:15 PM – 5:15 PM
(5-128) Anti-Xa Level Monitoring for Enoxaparin in COVID-19 Patients
Favorite
4:15 PM – 5:15 PM
(5-129) Efficacy of Long-Acting Injectable Antipsychotics versus Oral Antipsychotics in Preventing Psychiatric Rehospitalizations
Favorite
4:15 PM – 5:15 PM
(5-130) Developing and Assessing an Interprofessional Pharmacy Student Peer-Led Curriculum for Pre-Health Undergraduate Students
Favorite
4:15 PM – 5:15 PM
(5-131) Analysis on the Use of Platelet Function Assays in Neurological Patients
Favorite
4:15 PM – 5:15 PM
(5-132) Non-Small Cell Lung Cancer (NSCLC) Systematic Literature Review of New Mechanisms of Action in Phase II and III Clinical Trials
Favorite
4:15 PM – 5:15 PM
(5-133) Designing a Protocol to Remotely Control Hypertension in Concurrent Disease
Favorite
4:15 PM – 5:15 PM
(5-134) Medication Use Evaluation of COVID-19 Vaccination in Patients Receiving Immunosuppressive Therapy
Favorite
4:15 PM – 5:15 PM
(5-135) Trends in Pediatric Immunizations in the United States Between 2010 and 2020
Favorite
4:15 PM – 5:15 PM
(5-136) Population Pharmacokinetic Model of Carbamazepine Using Inpatient Therapeutic Drug Monitoring
Favorite
4:15 PM – 5:15 PM
(5-137) Review of State Regulations for Pharmacists Prescribing of Hormonal Contraceptives
Favorite
4:15 PM – 5:15 PM
(5-138) Assessment of Biosimilar Policy Implementation at a Community Medical Center
Favorite
4:15 PM – 5:15 PM
(5-139) Current Trends in FDA Form 483 Observations for 503B Outsourcing Facilities Through COVID-19
Favorite
4:15 PM – 5:15 PM
(5-140) Evaluation of State Board of Pharmacy 503B Outsourcing Requirements Across All 50 States
Favorite
4:15 PM – 5:15 PM
(5-142) Effects of Immune-Boosting Supplements on COVID-19 Symptoms
Favorite
4:15 PM – 5:15 PM
(5-143) Allergic versus Non-Allergic Angioedema: Using the Pharmacist Patient Care Process (PPCP) to Evaluate a Reaction to Angiotensin-Converting-Enzyme (ACE) Inhibitor Therapy in a Liver Transplant Patient
Favorite
4:15 PM – 5:15 PM
(5-144) Disruptors in the Retail Pharmacy Marketplace. Are They Effective?
Favorite
4:15 PM – 5:15 PM
(5-145) Assessing Clinical Studies Comparing Ruxolitinib to Current Standards of Care for the Treatment of Non-Segmental Vitiligo
Favorite
4:15 PM – 5:15 PM
(5-146) Evaluation of Adherence to Institutional Guidelines for the Use of Restricted Antibiotics
Favorite
4:15 PM – 5:15 PM
(5-147) Clinical Trial Variations of Current Investigational Drugs for Chemotherapy Induced Peripheral Neuropathy
Favorite
4:15 PM – 5:15 PM
(5-149) Evaluation of High Alert and Look-alike, Sound-alike Medication Competency in the Outpatient Setting of a Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-150) SGLT-2 Inhibitors Impact on Hospital Readmission Rates and Length of Stay in Heart Failure Patients
Favorite
4:15 PM – 5:15 PM
(5-151) An Analysis of COVID-Impacted Rutgers Pharmaceutical Industry Fellowship (RPIF) Interview Strategies and Perceptions: In-Person versus Virtual
Favorite
4:15 PM – 5:15 PM
(5-152) Evaluating Direct Oral Anticoagulant Appropriateness at a Community Hospital: A Retrospective Analysis
Favorite
4:15 PM – 5:15 PM
(5-153) Effect of Glucagon-Like Peptide-1 Receptor Agonists on Cardiovascular Outcomes: Systematic Literature Review
Favorite
4:15 PM – 5:15 PM
(5-154) Evaluation of Alcohol Withdrawal Syndrome Managed with Symptom-Triggered Benzodiazepines
Favorite
4:15 PM – 5:15 PM
(5-155) Critical Care: Pain and Agitation Management in Mechanically Ventilated Adults
Favorite
4:15 PM – 5:15 PM
(5-157) An Assessment of COVID-19 Clinical Trial Design Demographics and Outcome Measures Associated with Hydroxychloroquine and Ivermectin
Favorite
4:15 PM – 5:15 PM
(5-158) Elucidating the Mechanism of Inhibitory Activities of Riluzole in GRM1+ Melanoma Cells
Favorite
4:15 PM – 5:15 PM
(5-159) Analysis of FDA Warning Letters for Social Media Prescription Drug Promotion
Favorite
4:15 PM – 5:15 PM
(5-160) Analysis of Class of 2023 Fellowship Preferences
Favorite
4:15 PM – 5:15 PM
(5-161) Retrospective Evaluation of Short-Acting Injectable Antipsychotics for the Treatment of Agitation at a Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-162) Retrospective Evaluation of Benzodiazepine Related Fall Events Reported at a Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-163) Developmental Outcomes Associated with Fetal Exposure to Methadone and Buprenorphine: A Literature Review
Favorite
4:15 PM – 5:15 PM
(5-164) Effect of Blood Pressure Variability on Risk of Hemorrhagic Conversion in Patients That Received Alteplase for Acute Ischemic Stroke
Favorite
4:15 PM – 5:15 PM
(5-165) Effect of Augmented Renal Clearance on Vancomycin Trough Levels
Favorite
4:15 PM – 5:15 PM
(5-166) Monkeypox: A Disease Review, Current Treatment Strategies, and Ongoing Clinical Trials
Favorite
4:15 PM – 5:15 PM
(5-167) Evaluating the Timeliness of Administration, Cost, and Safety of Intravenous Push vs Intravenous Piggyback Levetiracetam: Single-Center, Retrospective Analysis
Favorite
4:15 PM – 5:15 PM
(5-168) Evaluating Cabotegravir/Rilpivirine Use for the Treatment of Human Immunodeficiency Virus (HIV) in an Interdisciplinary Ambulatory Care Clinic
Favorite
4:15 PM – 5:15 PM
(5-169) Glycemic Management in Adult Diabetic Inpatients at a Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-170) Bicalutamide: Prostate Carcinoma Medication Being Used for Gender Affirming Care
Favorite
4:15 PM – 5:15 PM
(5-171) Patient Perspectives and Needs Regarding Hormonal Contraception in Female Patients Living with HIV: A Qualitative Study
Favorite
4:15 PM – 5:15 PM
(5-173) Myoclonic-tonic Jerks Associated with Use of Buprenorphine and Cannabis
Favorite
4:15 PM – 5:15 PM
(5-174) COVID-19 Disease Disparities, Vaccination Care and Rates Influenced by Environmental Toxicants in the Cheyenne River Sioux Tribal Communities
Favorite
4:15 PM – 5:15 PM
(5-175) Re-engagement in Care for Patients with Positive Antibody Test for Hepatitis C Infection: A Descriptive Study at the University of New Mexico Hospital
Favorite
4:15 PM – 5:15 PM
(5-176) Identifying Factors Which Differentiate Patients with Controlled vs. Uncontrolled Migraines: A Retrospective Chart Review
Favorite
4:15 PM – 5:15 PM
(5-177) Evaluation of Patient Safety Program Intervention Potential and Staff Perception at University of New Mexico Hospitals
Favorite
4:15 PM – 5:15 PM
(5-178) Cautious Use of Paxlovid to Prevent Any Risk or Harm of Drug-drug Interactions
Favorite
4:15 PM – 5:15 PM
(5-179) Comparative Efficacy of Patiromer and Sodium Zirconium Cyclosilicate in Patients with Mild-to-Moderate Hyperkalemia
Favorite
4:15 PM – 5:15 PM
(5-180) Impact of a Pharmacist Driven Weight Loss Service in Evaluating Tolerability and Efficacy with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists
Favorite
4:15 PM – 5:15 PM
(5-181) Phosphate Binder Coverage by Medicare Part D Plans
Favorite
4:15 PM – 5:15 PM
(5-182) Association of AKI in Class III Obesity Patients Who Received Intravenous Vancomycin
Favorite
4:15 PM – 5:15 PM
(5-183) Improving Access to Contraception in New York State: Survey on the Expanding Role of the Community Pharmacist
Favorite
4:15 PM – 5:15 PM
(5-184) Examining the Circumstances Surrounding Phentolamine Administration for Vasopressor Extravasation in a Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-185) Supratherapeutic Cyclosporine and Sirolimus Levels in a Renal Transplant Patient with Concurrent Nirmatrelvir/Ritonavir Treatment
Favorite
4:15 PM – 5:15 PM
(5-186) Precipitated Opioid Withdrawal After Treatment with Buprenorphine-Naloxone
Favorite
4:15 PM – 5:15 PM
(5-187) Evaluation of an Institution-Specific Dose-Capping Protocol for Glucarpidase Administration in Patients Receiving High-Dose Methotrexate with Delayed Methotrexate Clearance
Favorite
4:15 PM – 5:15 PM
(5-188) Impact of a Hybrid Postgraduate Pharmacy Residency Preparation Course on Matching at Top Desired Programs
Favorite
4:15 PM – 5:15 PM
(5-189) Impact of COVID-19 on Industry Pharmacists Top Job Responsibilities
Favorite
4:15 PM – 5:15 PM
(5-190) Pharmacogenetic Guided Tool-Kit for Psychiatric Medications
Favorite
4:15 PM – 5:15 PM
(5-191) Assessing the Impact of a Pre-Pharmacy Scientific Writing Course on Student Performance in a Drug Information and Literature Evaluation Course
Favorite
4:15 PM – 5:15 PM
(5-192) Natural Nootropics May Promote Relaxation, Improve Cognitive Function, and Enhance Ability to Work Under Stressful Conditions
Favorite
4:15 PM – 5:15 PM
(5-193) Traditional Natural Products May Aid in Alleviation of Depressive Symptoms
Favorite
4:15 PM – 5:15 PM
(5-194) Appropriateness of Apixaban Dosing Before and After Implementation of Order Set in an Inpatient Setting at Community Teaching Hospital
Favorite
4:15 PM – 5:15 PM
(5-195) Case Report: Miller Fisher Syndrome and Suspected Bickerstaff Brainstem Encephalitis
Favorite
4:15 PM – 5:15 PM
(5-196) Is There an Alternative Vancomycin Combination Therapy with Reduced Risk of Acute Kidney Injury ? A Literature Review to Answer
Favorite
4:15 PM – 5:15 PM
(5-197) Examining Guideline Directed Prescribing Patterns of Type 2 Diabetes Mellitus Medications Across Various Areas of Practice Pre and Post Pharmacy-Led Educational Intervention
Favorite
4:15 PM – 5:15 PM
(5-198) Development of a Differential Scanning Fluorimetry Assay to Screen for Modulators of the Mycobacterium tuberculosis Prokaryotic Proteasome Pathway
Favorite
4:15 PM – 5:15 PM
(5-199) Evaluation of Candiduria Management at an Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-200) Assessing the Need for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals with Sexually Transmitted Infections (STIs) in a Large Tertiary Medical Center
Favorite
4:15 PM – 5:15 PM
(5-201) Role of Physiologically Relevant Conditions in Hormone Receptor Positive Breast Cancer Responsiveness to Chemotherapy
Favorite
4:15 PM – 5:15 PM
(5-202) Assessment of an Integrated Psychiatric Pharmacy Practice Within a Rural Internal Medicine Clinic
Favorite
4:15 PM – 5:15 PM
(5-203) Evaluating the Impact of an at Home Medication Disposal System on Safe Medication Disposal
Favorite
4:15 PM – 5:15 PM
(5-204) Combating the Opioid Epidemic with Opioid Use Disorder Awareness and Naloxone Training for Rural and Underserved Youth in Upstate New York
Favorite
4:15 PM – 5:15 PM
(5-205) Knowledge and Perceptions of New York State Women Towards Pharmacist Prescribed Hormonal Contraception
Favorite
4:15 PM – 5:15 PM
(5-206) Systematic Review of Non-thermal Plasma in the Treatment of Head and Neck Squamous Cell Carcinoma
Favorite
4:15 PM – 5:15 PM
(5-207) Comparison of Standard Dose versus Reduced Dose Apixaban for Atrial Fibrillation in Patients with End-Stage Renal Disease Receiving Hemodialysis
Favorite
4:15 PM – 5:15 PM
(5-208) Combination Nonthermal Plasma and Tirapazamine Targets Pancreatic Adenocarcinoma Cells via E-Cadherin Downregulation
Favorite
4:15 PM – 5:15 PM
(5-209) Baseline Population and Service Assessment to Implement Diabetes Self-Management Education and Support in a Community Pharmacy
Favorite
4:15 PM – 5:15 PM
(5-210) Systematic Review of Non-thermal Plasma in the Treatment of Melanoma
Favorite
4:15 PM – 5:15 PM
(5-211) Systematic Review of Non-thermal Plasma for the Treatment of Basal Cell Carcinoma
Favorite
4:15 PM – 5:15 PM
(5-212) Understanding the Knowledge and Skills Required for Interprofessional Education and Collaboration
Favorite
4:15 PM – 5:15 PM
(5-213) Retrospective Evaluation of Bromocriptine for Hyperthermia in Acute Brain Injured Patients
Favorite
4:15 PM – 5:15 PM
(5-214) Evaluating a Quality Assurance Shift’s Impact on Automated Dispensing Cabinet (ADC) Optimization
Favorite
4:15 PM – 5:15 PM
(5-215) Evaluation of Visual Field Loss and Safety Following Exposure to Vigabatrin for Infantile Spasms
Favorite
4:15 PM – 5:15 PM
(5-216) Remote Blood Pressure Monitoring Program in an Urban Clinic: A Single-Centered, Retrospective, Quality Improvement Project
Favorite
4:15 PM – 5:15 PM
(5-217) Treatment of Urinary Tract Infections in Roatan, Honduras
Favorite
4:15 PM – 5:15 PM
(5-218) Assessment of Vancomycin Concentrationsand Renal Function Changes in the Setting of Concomitant Intravenous Contrast Agentand VancomycinUseat a 241-Bed Community Teaching Hospital
Favorite
4:15 PM – 5:15 PM
(5-219) Selection of Antibiotic Treatment for Patients with Head and Neck Injuries in the Surgical Intensive Care Unit (SICU)
Favorite
4:15 PM – 5:15 PM
(5-220) Feasibility of Pharmacy Student Initiated Proton Pump Inhibitor Interchange Program
Favorite
4:15 PM – 5:15 PM
(5-221) Implementation of Epic Willow Dispense Prep for Non-Sterile Preparations
Favorite
4:15 PM – 5:15 PM
(5-222) Student Pharmacist Confidence to Perform Pharmacy Services and Their Appeal for Suicide Prevention
Favorite
4:15 PM – 5:15 PM
(5-223) Formulation and Stability of Low-Dose Aspirin Capsules for the Use of Aspirin Desensitization
Favorite
4:15 PM – 5:15 PM
(5-224) Role of Combination Adjuvants in Immunotherapy
Favorite
4:15 PM – 5:15 PM
(5-225) Evaluation of Hypertension Management in Underserved Patients in Rochester, NY
Favorite
4:15 PM – 5:15 PM
(5-226) Assessing the Effectiveness of Hypertension Treatment Regimens in a Rural Tanzanian Clinic
Favorite
4:15 PM – 5:15 PM
(5-227) Evaluation of Access to Helicobacter pylori Treatment in Newly Resettled Refugees with a Pharmacist-led Multidisciplinary Team
Favorite
4:15 PM – 5:15 PM
(5-228) Impact of the Reaching Children’s Potential Program on Improving Health Outcomes in Rural Villages in Tanzania
Favorite
4:15 PM – 5:15 PM
(5-229) Identification of the Need to Develop Guidance for Therapeutic Conversions from GLP-1 Agonists to the Combined GIP/GLP-1 Agonist Tirzepatide
Favorite
4:15 PM – 5:15 PM
(5-230) Retrospective Evaluation of Intravenous Levothyroxine Use Following Guideline Implementation
Favorite
4:15 PM – 5:15 PM
(5-231) Evaluation of Intravenous Levothyroxine Utilization in the Adult Inpatient Population at a City Hospital
Favorite
4:15 PM – 5:15 PM
(5-232) The Effects of Major Modifiable Risk Factors on Blood Pressure Levels in US Adults Not Taking Antihypertensive Therapy
Favorite
4:15 PM – 5:15 PM
(5-233) Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States Adults with Hypertension, the National Health and Nutrition Examination Survey, 2001 to 2020
Favorite
4:15 PM – 5:15 PM
(5-234) Evaluation of Outpatient Upper Respiratory Tract Infection Prescribing Patterns at a City Hospital
Favorite
4:15 PM – 5:15 PM
(5-141) A Retrospective Evaluation of Perioperative Anticoagulation Management at a Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-236) Evaluation of Emergency Room Discharge Antibiotic Prescribing Patterns at a City Hospital
Favorite
4:15 PM – 5:15 PM
(5-237) Evaluation of Antibiotic Prescribing Practices for the Treatment of Multi-Drug Resistant Urinary Pathogens at a City Hospital
Favorite
4:15 PM – 5:15 PM
(5-238) Evaluation of the Incidence of Multi-drug Resistant Urinary Pathogens Among the General-inpatient Medicine Population at a City Hospital
Favorite
4:15 PM – 5:15 PM
(5-239) Student Engagement Pre and Post COVID-19 Pandemic
Favorite
4:15 PM – 5:15 PM
(5-240) Evaluating the Implications and Effects of Dihydropyrimidine Dehydrogenase Deficiency (DPD)
Favorite
4:15 PM – 5:15 PM
(5-241) New York State Pharmacists’ Perspectives on the Utilization of Post-Graduation and Advanced Certification Education to Provide Essential Care as Healthcare Providers
Favorite
4:15 PM – 5:15 PM
(5-242) Pharmacists’ Involvement in COVID-19 Related Services During the Pandemic and Implications for Expansion of Scope of Pharmacy Practice in New York State
Favorite
4:15 PM – 5:15 PM
(5-243) Efficacy and Safety of Amantadine in the Intensive Care Unit (ICU) for Patients with Traumatic Brain Injury and Limited Neurological Recovery
Favorite
4:15 PM – 5:15 PM
(5-244) Health Misinformation and Disinformation on Social Media: A Systematic Narrative Review
Favorite
4:15 PM – 5:15 PM
(5-245) Tacrolimus Dose and Time to Therapeutic Range in Pediatric Renal Transplant Patients
Favorite
4:15 PM – 5:15 PM
(5-246) Impact of Peer Education in Advanced Pharmacy Practice Experiences on Pharmacy Student Learning
Favorite
4:15 PM – 5:15 PM
(5-247) Medication Use Evaluation of Aztreonam at Nassau University Medical Center (NUMC)
Favorite
4:15 PM – 5:15 PM
(5-248) Evaluation of Time to Therapeutic Activated Partial Thromboplastin Time in Patients on Unfractionated Heparin Infusion Among Different Weight Categories
Favorite
4:15 PM – 5:15 PM
(5-249) Compliance with Activated Partial Thromboplastin Time (aPTT) Monitoring and Heparin Infusion Dosing Adjustments as Part of a Hospital Dosing Nomogram in Adults
Favorite
4:15 PM – 5:15 PM
(5-250) Medication Use Evaluation of Lidocaine Intravenous Infusion for Perioperative Analgesia in Emergency Surgery Patients
Favorite
4:15 PM – 5:15 PM
(5-251) Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screens at Nassau University Medical Center (NUMC)
Favorite
4:15 PM – 5:15 PM
(5-252) Comparing the Effectiveness of Keytruda Against Non-Small Cell Lung Cancer and Triple Negative Breast Cancer
Favorite
4:15 PM – 5:15 PM
(5-253) Characterization of Antidepressant Medications Inducing Suicidal Ideation in Pediatric Populations
Favorite
4:15 PM – 5:15 PM
(5-254) Establishing a Professional Development Event for Pharmacy Students
Favorite
4:15 PM – 5:15 PM
(5-256) Pharmacists Awareness and Comfort Surrounding Updated Clostridioides Difficile Guidelines
Favorite
4:15 PM – 5:15 PM
(5-257) It Takes Two to Tango: Improving the Efficacy of Bacteriophage Therapy Through Strategic Combination of Two Clinically Relevant Bacteriophages Against Pseudomonas Aeruginosa
Favorite
4:15 PM – 5:15 PM
(5-258) Evaluation of Intensive Care Unit Admissions Following the Implementation of a Computerized Insulin Dosing Tool for the Management of Diabetic Ketoacidosis in the Emergency Department
Favorite
4:15 PM – 5:15 PM
(5-259) Acceptance Rates into the Rho Chi Society - Beta Theta Chapter: Identifying Trends and Possible Factors Contributing to Change
Favorite
4:15 PM – 5:15 PM
(5-260) Efficacy of Tirzepatide, a GIP/GLP-1 Agonist, in the Treatment of Type 2 Diabetes: A Systematic Review
Favorite
4:15 PM – 5:15 PM
(5-261) The Effect of Probiotics on Respiratory Pathogens
Favorite
4:15 PM – 5:15 PM
(5-262) Clinical Conundrums: Differentiating Monkeypox from Similarly Presenting Infections
Favorite
4:15 PM – 5:15 PM
(5-263) Two Amino-acid Polymorphisms in PBP4 Generate Penicillin Tolerance in Group B Streptococcus (GBS)
Favorite
4:15 PM – 5:15 PM
(5-264) Evaluation of Clinical Outcomes of Empiric Antimicrobial Regimens for Patients at Low Risk of Methicillin Resistant Staphylococcus aureus
Favorite
4:15 PM – 5:15 PM
(5-265) Antimicrobial Effects of Cannabinoids on Pseudomonas Aeruginosa
Favorite
4:15 PM – 5:15 PM
(5-266) The Effect of Antibiotic Treatment and the Role of Efflux Transporters on Resistance in Pseudomonas Aeruginosa Biofilms
Favorite
4:15 PM – 5:15 PM
(5-267) Assessment of Individual Patient Factors and Impact on Patient Satisfaction with Medication Regimen and Willingness to Deprescribe
Favorite
4:15 PM – 5:15 PM
(5-268) Effects of Bictegravir: Polypharmacy versus Non-polypharmacy
Favorite
4:15 PM – 5:15 PM
(5-269) Characterization of Treatment of Diabetes in COVID-19 Hospitalized Patients
Favorite
4:15 PM – 5:15 PM
(5-270) Gauging the Impact of COVID-19 on Chronic Disease Treatment Through a Pharmacotherapeutic Lens
Favorite
4:15 PM – 5:15 PM
(5-271) Risk Assessment of Patients Treated with and Without Therapeutic Anticoagulation for Atrial Fibrillation in the Intensive Care Unit
Favorite
4:15 PM – 5:15 PM
(5-272) Impact of Pre-Operative P2Y12 Platelet Reactivity Units on Peri- and Post-Operative Bleeding Events in Cardiac Surgery Patients
Favorite
4:15 PM – 5:15 PM
(5-273) Evaluation of Ivabradine Utilization Within a Western New York Health System
Favorite
4:15 PM – 5:15 PM
(5-274) Descriptive Analysis of Photovoice Activity Addressing the Social Determinants of Health
Favorite
4:15 PM – 5:15 PM
(5-275) Aztreonam-Induced Persistence of Pseudomonas Aeruginosa: Clinical Implications of Optimal Use of β-lactam Antibiotics
Favorite
4:15 PM – 5:15 PM
(5-276) Vancomycin Therapeutic Target Achievement in Obese Patients Undergoing Replacement Arthroplasty Procedures
Favorite
4:15 PM – 5:15 PM
(5-277) Investigating Viable Monobactam and 𝜷-lactamase Inhibitor-based Combinations versus Pan-resistant K. Pneumoniae Utilizing the Disc Diffusion Synergy Test
Favorite
4:15 PM – 5:15 PM
(5-278) Impact of Medication Optimization and Recommendations by Clinical Pharmacists Embedded in a Memory Disorder Clinic
Favorite
4:15 PM – 5:15 PM
(5-279) Evaluation of Community Pharmacists’ Recommendations Regarding Raspberry Leaf Products for the Facilitation of Parturition: A Mystery Caller Approach
Favorite
4:15 PM – 5:15 PM
(5-280) Time Study of Specialty Pharmacy Team Member Interactions with Field Representatives from Pharmaceutical Companies
Favorite
4:15 PM – 5:15 PM
(5-281) Pharmacy Student Involvement in Improving Antimicrobial Intravenous to Oral Conversion Time in a Community Teaching Hospital
Favorite
4:15 PM – 5:15 PM
(5-282) Evaluation of a Multidisciplinary Approach to the Treatment of Latent Tuberculosis in Refugee Patients in the Primary Care Setting
Favorite
4:15 PM – 5:15 PM
(5-283) Chemical Stability of Aspirin in Novel Anhydrous Oral Vehicles
Favorite
4:15 PM – 5:15 PM
(5-284) Evaluation of Treatment Approaches for Chronic Deep Vein Thrombosis (DVT)
Favorite
4:15 PM – 5:15 PM
(5-285) Survey of New York State Health Department Leaders: Understanding Utilization, Impact, and Obstacles to Pharmacists Working Within Local Health Departments
Favorite
4:15 PM – 5:15 PM
(5-286) Development of Educational Resources for Healthcare Providers at a Center for Underserved Patients
Favorite
4:15 PM – 5:15 PM
(5-287) Impact of Removing Oral Lorazepam from Inpatient Psychiatry Order Set at an Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-172) 3D Printed Mimetic Human Induction Ports Effect the Deposition of Inhalation Aerosols
Favorite
4:15 PM – 5:15 PM
(5-156) 10-year Demographic Analysis of Racial and Ethnic Diversity of Underrepresented Populations in Clinical Trials Within FDA Approved Cardiometabolic Drugs
Favorite
4:15 PM – 5:15 PM
(5-235) A Retrospective Cohort Study Evaluating the Appropriateness of Empiric Antibiotic Prescribing in Patients with Multi-Drug Resistant (MDR) Bacteremia at a City Hospital
Favorite
4:15 PM – 5:15 PM
(5-148) A Survey of Pharmacy Students in Big Ten Schools to Determine the Factors That Motivate Students to Pursue a Career in Pharmacy
Favorite
Back to Top
